Category,CategoryID,GO,Description,PARENT_GO,LogP,Enrichment,Z-score,#TotalGeneInLibrary,#GeneInGO,#GeneInHitList,#GeneInGOAndHitList,%InGO,STDV %InGO,GeneID,Hits,Log(q-value),GeneList
Reactome Gene Sets,6,R-HSA-5673001,RAF/MAP kinase cascade,,-6.3,8.1,7.9,30286,280,134,10,7.5,2.3,71|808|2246|2263|3567|4747|7010|7314|7529|8452,ACTG1|CALM3|FGF1|FGFR2|IL5|NEFL|TEK|UBB|YWHAB|CUL3,-2.2,Ccdc115
Reactome Gene Sets,6,R-HSA-5684996,MAPK1/MAPK3 signaling,,-6.2,7.9,7.8,30286,286,134,10,7.5,2.3,71|808|2246|2263|3567|4747|7010|7314|7529|8452,ACTG1|CALM3|FGF1|FGFR2|IL5|NEFL|TEK|UBB|YWHAB|CUL3,-2.2,Ccdc115
GO Biological Processes,19,GO:0060322,head development,19_GO:0032502 developmental process,-5.7,4.4,6.3,30286,778,134,15,11,2.7,808|2263|3184|4747|5354|7314|7337|8633|9037|9963|23767|27429|57142|64805|93986,CALM3|FGFR2|HNRNPD|NEFL|PLP1|UBB|UBE3A|UNC5C|SEMA5A|SLC23A1|FLRT3|HTRA2|RTN4|P2RY12|FOXP2,-2,Ccdc115
Reactome Gene Sets,6,R-HSA-5683057,MAPK family signaling cascades,,-5.7,7,7.2,30286,325,134,10,7.5,2.3,71|808|2246|2263|3567|4747|7010|7314|7529|8452,ACTG1|CALM3|FGF1|FGFR2|IL5|NEFL|TEK|UBB|YWHAB|CUL3,-2,Ccdc115
GO Biological Processes,19,GO:0007420,brain development,19_GO:0032502 developmental process,-5.3,4.3,6.1,30286,729,134,14,10,2.6,808|2263|3184|4747|5354|7314|7337|8633|9037|9963|27429|57142|64805|93986,CALM3|FGFR2|HNRNPD|NEFL|PLP1|UBB|UBE3A|UNC5C|SEMA5A|SLC23A1|HTRA2|RTN4|P2RY12|FOXP2,-1.7,Ccdc115
GO Biological Processes,19,GO:0051338,regulation of transferase activity,19_GO:0065007 biological regulation,-5.3,4.6,6.1,30286,639,134,13,9.7,2.6,808|2246|2263|2321|3184|3326|3357|4067|4869|7010|55450|57515|128344,CALM3|FGF1|FGFR2|FLT1|HNRNPD|HSP90AB1|HTR2B|LYN|NPM1|TEK|CAMK2N1|SERINC1|CIMAP3,-1.7,Ccdc115
GO Biological Processes,19,GO:0051347,positive regulation of transferase activity,19_GO:0065007 biological regulation,-5.2,6,6.5,30286,375,134,10,7.5,2.3,808|2246|2263|2321|3184|3326|3357|7010|57515|128344,CALM3|FGF1|FGFR2|FLT1|HNRNPD|HSP90AB1|HTR2B|TEK|SERINC1|CIMAP3,-1.7,Ccdc115
GO Biological Processes,19,GO:1902115,regulation of organelle assembly,19_GO:0050789 regulation of biological process,-5.1,8.1,7.1,30286,223,134,8,6,2,1540|3567|4869|29978|92421|246175|347240|347730,CYLD|IL5|NPM1|UBQLN2|CHMP4C|CNOT6L|KIF24|LRRTM1,-1.7,Ccdc115
GO Biological Processes,19,GO:0031175,neuron projection development,19_GO:0032502 developmental process,-4.9,4.3,5.8,30286,691,134,13,9.7,2.6,71|658|2263|2823|4067|4747|5354|5532|7314|8633|9037|23767|57142,ACTG1|BMPR1B|FGFR2|GPM6A|LYN|NEFL|PLP1|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3|RTN4,-1.6,Ccdc115
GO Biological Processes,19,GO:1902749,regulation of cell cycle G2/M phase transition,19_GO:0050789 regulation of biological process,-4.9,12,7.7,30286,116,134,6,4.5,1.8,4869|4998|55743|79184|92421|373509,NPM1|ORC1|CHFR|BRCC3|CHMP4C|USP50,-1.6,Ccdc115
GO Biological Processes,19,GO:0060736,prostate gland growth,19_GO:0040007 growth,-4.9,62,13,30286,11,134,3,2.2,1.3,367|2263|7337,AR|FGFR2|UBE3A,-1.6,Ccdc115
GO Biological Processes,19,GO:0061564,axon development,19_GO:0032502 developmental process,-4.7,5.4,6,30286,421,134,10,7.5,2.3,71|658|2263|4747|5354|5532|8633|9037|23767|57142,ACTG1|BMPR1B|FGFR2|NEFL|PLP1|PPP3CB|UNC5C|SEMA5A|FLRT3|RTN4,-1.5,Ccdc115
GO Biological Processes,19,GO:0051302,regulation of cell division,19_GO:0050789 regulation of biological process,-4.7,8.5,6.8,30286,186,134,7,5.2,1.9,808|2124|2246|2263|3357|8452|92421,CALM3|EVI2B|FGF1|FGFR2|HTR2B|CUL3|CHMP4C,-1.5,Ccdc115
GO Biological Processes,19,GO:0045766,positive regulation of angiogenesis,19_GO:0032502 developmental process,-4.7,8.5,6.8,30286,187,134,7,5.2,1.9,285|2246|2321|6019|7010|9037|27329,ANGPT2|FGF1|FLT1|RLN2|TEK|SEMA5A|ANGPTL3,-1.5,Ccdc115
GO Biological Processes,19,GO:0002831,regulation of response to biotic stimulus,19_GO:0050896 response to stimulus,-4.6,4.7,5.8,30286,524,134,11,8.2,2.4,1540|1687|4067|5094|7534|10758|57142|64922|79184|92610|373509,CYLD|GSDME|LYN|PCBP2|YWHAZ|TRAF3IP2|RTN4|LRRC19|BRCC3|TIFA|USP50,-1.5,Ccdc115
GO Biological Processes,19,GO:1904018,positive regulation of vasculature development,19_GO:0032502 developmental process,-4.6,8.3,6.8,30286,190,134,7,5.2,1.9,285|2246|2321|6019|7010|9037|27329,ANGPT2|FGF1|FLT1|RLN2|TEK|SEMA5A|ANGPTL3,-1.5,Ccdc115
GO Biological Processes,19,GO:0035589,G protein-coupled purinergic nucleotide receptor signaling pathway,19_GO:0050896 response to stimulus,-4.6,52,12,30286,13,134,3,2.2,1.3,2857|9934|64805,GPR34|P2RY14|P2RY12,-1.5,Ccdc115
GO Biological Processes,19,GO:0043549,regulation of kinase activity,19_GO:0008152 metabolic process,-4.6,4.7,5.7,30286,532,134,11,8.2,2.4,808|2246|2263|2321|3326|3357|4067|4869|7010|55450|128344,CALM3|FGF1|FGFR2|FLT1|HSP90AB1|HTR2B|LYN|NPM1|TEK|CAMK2N1|CIMAP3,-1.5,Ccdc115
GO Biological Processes,19,GO:0031396,regulation of protein ubiquitination,19_GO:0008152 metabolic process,-4.5,8,6.6,30286,198,134,7,5.2,1.9,3326|4869|7314|7337|8452|55743|84707,HSP90AB1|NPM1|UBB|UBE3A|CUL3|CHFR|BEX2,-1.5,Ccdc115
GO Biological Processes,19,GO:0031401,positive regulation of protein modification process,19_GO:0048518 positive regulation of biological process,-4.4,3.8,5.3,30286,764,134,13,9.7,2.6,808|2246|2321|3326|3357|3567|4067|4869|7010|7314|7337|8452|55743,CALM3|FGF1|FLT1|HSP90AB1|HTR2B|IL5|LYN|NPM1|TEK|UBB|UBE3A|CUL3|CHFR,-1.4,Ccdc115
Reactome Gene Sets,6,R-HSA-9678108,SARS-CoV-1 Infection,,-4.4,9.5,6.8,30286,142,134,6,4.5,1.8,4869|5094|7314|7529|7534|92421,NPM1|PCBP2|UBB|YWHAB|YWHAZ|CHMP4C,-1.4,Ccdc115
GO Biological Processes,19,GO:0032103,positive regulation of response to external stimulus,19_GO:0048518 positive regulation of biological process,-4.4,4.4,5.5,30286,561,134,11,8.2,2.4,1540|4067|5734|9037|55450|57142|64805|64922|79184|92610|373509,CYLD|LYN|PTGER4|SEMA5A|CAMK2N1|RTN4|P2RY12|LRRC19|BRCC3|TIFA|USP50,-1.4,Ccdc115
KEGG Pathway,24,hsa04015,Rap1 signaling pathway,,-4.4,7.5,6.3,30286,210,134,7,5.2,1.9,71|285|808|2246|2263|2321|7010,ACTG1|ANGPT2|CALM3|FGF1|FGFR2|FLT1|TEK,-1.4,Ccdc115
CORUM,33,CORUM:5199,Kinase maturation complex 1,,-4.3,42,11,30286,16,134,3,2.2,1.3,3326|7529|7534,HSP90AB1|YWHAB|YWHAZ,-1.4,Ccdc115
Reactome Gene Sets,6,R-HSA-190236,Signaling by FGFR,,-4.3,13,7.4,30286,89,134,5,3.7,1.6,2246|2263|3187|7314|23767,FGF1|FGFR2|HNRNPH1|UBB|FLRT3,-1.4,Ccdc115
GO Biological Processes,19,GO:0030850,prostate gland development,19_GO:0022414 reproductive process,-4.3,20,8.4,30286,46,134,4,3,1.5,367|2263|7337|55840,AR|FGFR2|UBE3A|EAF2,-1.4,Ccdc115
GO Biological Processes,19,GO:0000902,cell morphogenesis,19_GO:0032502 developmental process,-4.3,4,5.2,30286,681,134,12,9,2.5,71|367|658|2263|2823|4747|5532|7314|8452|8633|9037|23767,ACTG1|AR|BMPR1B|FGFR2|GPM6A|NEFL|PPP3CB|UBB|CUL3|UNC5C|SEMA5A|FLRT3,-1.4,Ccdc115
GO Biological Processes,19,GO:0050679,positive regulation of epithelial cell proliferation,19_GO:0048518 positive regulation of biological process,-4.2,7.2,6.2,30286,219,134,7,5.2,1.9,367|2246|2263|3357|7010|9037|57142,AR|FGF1|FGFR2|HTR2B|TEK|SEMA5A|RTN4,-1.4,Ccdc115
Reactome Gene Sets,6,R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",,-4.2,19,8.2,30286,48,134,4,3,1.5,3567|4067|7314|7534,IL5|LYN|UBB|YWHAZ,-1.4,Ccdc115
GO Biological Processes,19,GO:0048812,neuron projection morphogenesis,19_GO:0032502 developmental process,-4.2,4.7,5.4,30286,484,134,10,7.5,2.3,71|658|2263|2823|4747|5532|7314|8633|9037|23767,ACTG1|BMPR1B|FGFR2|GPM6A|NEFL|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-1.4,Ccdc115
GO Biological Processes,19,GO:0033674,positive regulation of kinase activity,19_GO:0048518 positive regulation of biological process,-4.2,6,5.8,30286,302,134,8,6,2,808|2246|2263|2321|3326|3357|7010|128344,CALM3|FGF1|FGFR2|FLT1|HSP90AB1|HTR2B|TEK|CIMAP3,-1.4,Ccdc115
GO Biological Processes,19,GO:0120039,plasma membrane bounded cell projection morphogenesis,19_GO:0032502 developmental process,-4.2,4.6,5.4,30286,489,134,10,7.5,2.3,71|658|2263|2823|4747|5532|7314|8633|9037|23767,ACTG1|BMPR1B|FGFR2|GPM6A|NEFL|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-1.4,Ccdc115
Reactome Gene Sets,6,R-HSA-9692914,SARS-CoV-1-host interactions,,-4.2,12,7,30286,96,134,5,3.7,1.6,4869|5094|7314|7529|7534,NPM1|PCBP2|UBB|YWHAB|YWHAZ,-1.4,Ccdc115
GO Biological Processes,19,GO:0002833,positive regulation of response to biotic stimulus,19_GO:0048518 positive regulation of biological process,-4.2,5.9,5.7,30286,307,134,8,6,2,1540|1687|4067|57142|64922|79184|92610|373509,CYLD|GSDME|LYN|RTN4|LRRC19|BRCC3|TIFA|USP50,-1.4,Ccdc115
GO Biological Processes,19,GO:0010562,positive regulation of phosphorus metabolic process,19_GO:0048518 positive regulation of biological process,-4.2,3.9,5.1,30286,702,134,12,9,2.5,367|808|2246|2263|2321|3326|3357|3567|4067|7010|23682|128344,AR|CALM3|FGF1|FGFR2|FLT1|HSP90AB1|HTR2B|IL5|LYN|TEK|RAB38|CIMAP3,-1.4,Ccdc115
GO Biological Processes,19,GO:0045937,positive regulation of phosphate metabolic process,19_GO:0048518 positive regulation of biological process,-4.2,3.9,5.1,30286,702,134,12,9,2.5,367|808|2246|2263|2321|3326|3357|3567|4067|7010|23682|128344,AR|CALM3|FGF1|FGFR2|FLT1|HSP90AB1|HTR2B|IL5|LYN|TEK|RAB38|CIMAP3,-1.4,Ccdc115
GO Biological Processes,19,GO:0048858,cell projection morphogenesis,19_GO:0032502 developmental process,-4.1,4.6,5.3,30286,494,134,10,7.5,2.3,71|658|2263|2823|4747|5532|7314|8633|9037|23767,ACTG1|BMPR1B|FGFR2|GPM6A|NEFL|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-1.4,Ccdc115
KEGG Pathway,24,hsa04390,Hippo signaling pathway,,-4.1,8.6,6.4,30286,157,134,6,4.5,1.8,71|658|2246|7529|7534|29119,ACTG1|BMPR1B|FGF1|YWHAB|YWHAZ|CTNNA3,-1.4,Ccdc115
GO Biological Processes,19,GO:0010517,regulation of phospholipase activity,19_GO:0065007 biological regulation,-4.1,17,7.9,30286,52,134,4,3,1.5,2263|2321|3357|27329,FGFR2|FLT1|HTR2B|ANGPTL3,-1.3,Ccdc115
GO Biological Processes,19,GO:0050678,regulation of epithelial cell proliferation,19_GO:0050789 regulation of biological process,-4.1,5,5.4,30286,407,134,9,6.7,2.2,367|2246|2263|2321|3357|7010|9037|55840|57142,AR|FGF1|FGFR2|FLT1|HTR2B|TEK|SEMA5A|EAF2|RTN4,-1.3,Ccdc115
GO Biological Processes,19,GO:0007167,enzyme-linked receptor protein signaling pathway,19_GO:0050896 response to stimulus,-4,4,5.1,30286,614,134,11,8.2,2.4,285|367|658|2246|2263|2321|4067|7010|9068|23767|91851,ANGPT2|AR|BMPR1B|FGF1|FGFR2|FLT1|LYN|TEK|ANGPTL1|FLRT3|CHRDL1,-1.3,Ccdc115
Reactome Gene Sets,6,R-HSA-8953854,Metabolism of RNA,,-4,3.7,5,30286,726,134,12,9,2.5,3184|3187|4809|5094|7314|7529|7534|23283|51691|220988|246175|403314,HNRNPD|HNRNPH1|SNU13|PCBP2|UBB|YWHAB|YWHAZ|CSTF2T|LSM8|HNRNPA3|CNOT6L|APOBEC4,-1.3,Ccdc115
Reactome Gene Sets,6,R-HSA-69481,G2/M Checkpoints,,-4,8.1,6.2,30286,167,134,6,4.5,1.8,4998|5000|7314|7529|7534|79184,ORC1|ORC4|UBB|YWHAB|YWHAZ|BRCC3,-1.3,Ccdc115
GO Biological Processes,19,GO:1903320,regulation of protein modification by small protein conjugation or removal,19_GO:0008152 metabolic process,-4,6.6,5.8,30286,241,134,7,5.2,1.9,3326|4869|7314|7337|8452|55743|84707,HSP90AB1|NPM1|UBB|UBE3A|CUL3|CHFR|BEX2,-1.3,Ccdc115
GO Biological Processes,19,GO:0034605,cellular response to heat,19_GO:0050896 response to stimulus,-4,16,7.6,30286,55,134,4,3,1.5,2246|3326|4067|27429,FGF1|HSP90AB1|LYN|HTRA2,-1.3,Ccdc115
GO Biological Processes,19,GO:0042327,positive regulation of phosphorylation,19_GO:0048518 positive regulation of biological process,-4,4,5,30286,623,134,11,8.2,2.4,367|808|2246|2263|2321|3326|3357|3567|4067|7010|128344,AR|CALM3|FGF1|FGFR2|FLT1|HSP90AB1|HTR2B|IL5|LYN|TEK|CIMAP3,-1.3,Ccdc115
GO Biological Processes,19,GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,19_GO:0050896 response to stimulus,-4,4.9,5.3,30286,419,134,9,6.7,2.2,285|367|2246|2263|2321|4067|7010|9068|23767,ANGPT2|AR|FGF1|FGFR2|FLT1|LYN|TEK|ANGPTL1|FLRT3,-1.3,Ccdc115
GO Biological Processes,19,GO:0048678,response to axon injury,19_GO:0050896 response to stimulus,-3.9,16,7.6,30286,56,134,4,3,1.5,4067|4747|23767|64805,LYN|NEFL|FLRT3|P2RY12,-1.3,Ccdc115
GO Biological Processes,19,GO:0031349,positive regulation of defense response,19_GO:0048518 positive regulation of biological process,-3.9,4.8,5.3,30286,422,134,9,6.7,2.2,1540|4067|5734|55450|57142|64922|79184|92610|373509,CYLD|LYN|PTGER4|CAMK2N1|RTN4|LRRC19|BRCC3|TIFA|USP50,-1.3,Ccdc115
GO Biological Processes,19,GO:1901873,regulation of post-translational protein modification,19_GO:0008152 metabolic process,-3.9,6.4,5.7,30286,246,134,7,5.2,1.9,3326|4869|7314|7337|8452|55743|84707,HSP90AB1|NPM1|UBB|UBE3A|CUL3|CHFR|BEX2,-1.3,Ccdc115
GO Biological Processes,19,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,19_GO:0048518 positive regulation of biological process,-3.9,7.9,6.1,30286,171,134,6,4.5,1.8,2321|7010|7337|9037|57142|64805,FLT1|TEK|UBE3A|SEMA5A|RTN4|P2RY12,-1.3,Ccdc115
GO Biological Processes,19,GO:0050673,epithelial cell proliferation,19_GO:0009987 cellular process,-3.9,7.9,6.1,30286,171,134,6,4.5,1.8,367|2246|2263|7010|9037|55840,AR|FGF1|FGFR2|TEK|SEMA5A|EAF2,-1.3,Ccdc115
GO Biological Processes,19,GO:0031398,positive regulation of protein ubiquitination,19_GO:0048518 positive regulation of biological process,-3.9,10,6.6,30286,108,134,5,3.7,1.6,4869|7314|7337|8452|55743,NPM1|UBB|UBE3A|CUL3|CHFR,-1.3,Ccdc115
GO Biological Processes,19,GO:0001525,angiogenesis,19_GO:0032502 developmental process,-3.9,5.3,5.4,30286,338,134,8,6,2,71|285|2246|2263|2321|7010|9037|27329,ACTG1|ANGPT2|FGF1|FGFR2|FLT1|TEK|SEMA5A|ANGPTL3,-1.3,Ccdc115
Reactome Gene Sets,6,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,,-3.9,4.2,5,30286,534,134,10,7.5,2.3,71|808|2246|2263|2321|3187|4067|7314|7529|23767,ACTG1|CALM3|FGF1|FGFR2|FLT1|HNRNPH1|LYN|UBB|YWHAB|FLRT3,-1.3,Ccdc115
Reactome Gene Sets,6,R-HSA-9013418,RHOBTB2 GTPase cycle,,-3.9,29,9.1,30286,23,134,3,2.2,1.3,71|3326|8452,ACTG1|HSP90AB1|CUL3,-1.3,Ccdc115
GO Biological Processes,19,GO:0045088,regulation of innate immune response,19_GO:0044419 biological process involved in interspecies interaction between organisms,-3.8,4.6,5.1,30286,440,134,9,6.7,2.2,1540|4067|5094|7534|57142|64922|79184|92610|373509,CYLD|LYN|PCBP2|YWHAZ|RTN4|LRRC19|BRCC3|TIFA|USP50,-1.2,Ccdc115
GO Biological Processes,19,GO:0001655,urogenital system development,19_GO:0032502 developmental process,-3.7,14,7.1,30286,63,134,4,3,1.5,367|2263|7337|55840,AR|FGFR2|UBE3A|EAF2,-1.2,Ccdc115
GO Biological Processes,19,GO:0032102,negative regulation of response to external stimulus,19_GO:0048519 negative regulation of biological process,-3.7,4.5,5,30286,453,134,9,6.7,2.2,285|1540|4067|4907|5094|5734|7010|7534|9037,ANGPT2|CYLD|LYN|NT5E|PCBP2|PTGER4|TEK|YWHAZ|SEMA5A,-1.2,Ccdc115
GO Biological Processes,19,GO:0043408,regulation of MAPK cascade,19_GO:0050896 response to stimulus,-3.7,3.7,4.7,30286,669,134,11,8.2,2.4,367|1540|1687|2246|2263|2321|3357|4067|4988|7010|7534,AR|CYLD|GSDME|FGF1|FGFR2|FLT1|HTR2B|LYN|OPRM1|TEK|YWHAZ,-1.2,Ccdc115
KEGG Pathway,24,hsa04151,PI3K-Akt signaling pathway,,-3.7,5,5.1,30286,359,134,8,6,2,285|2246|2263|2321|3326|7010|7529|7534,ANGPT2|FGF1|FGFR2|FLT1|HSP90AB1|TEK|YWHAB|YWHAZ,-1.1,Ccdc115
GO Biological Processes,19,GO:0007409,axonogenesis,19_GO:0032502 developmental process,-3.6,4.9,5.1,30286,366,134,8,6,2,71|658|2263|4747|5532|8633|9037|23767,ACTG1|BMPR1B|FGFR2|NEFL|PPP3CB|UNC5C|SEMA5A|FLRT3,-1.1,Ccdc115
GO Biological Processes,19,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,19_GO:0048519 negative regulation of biological process,-3.6,13,6.8,30286,68,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:0060191,regulation of lipase activity,19_GO:0065007 biological regulation,-3.6,13,6.7,30286,69,134,4,3,1.5,2263|2321|3357|27329,FGFR2|FLT1|HTR2B|ANGPTL3,-1.1,Ccdc115
GO Biological Processes,19,GO:0035590,purinergic nucleotide receptor signaling pathway,19_GO:0050896 response to stimulus,-3.6,24,8.2,30286,28,134,3,2.2,1.3,2857|9934|64805,GPR34|P2RY14|P2RY12,-1.1,Ccdc115
GO Biological Processes,19,GO:0045089,positive regulation of innate immune response,19_GO:0044419 biological process involved in interspecies interaction between organisms,-3.6,5.6,5.2,30286,281,134,7,5.2,1.9,1540|4067|57142|64922|79184|92610|373509,CYLD|LYN|RTN4|LRRC19|BRCC3|TIFA|USP50,-1.1,Ccdc115
Reactome Gene Sets,6,R-HSA-1640170,Cell Cycle,,-3.6,3.6,4.6,30286,692,134,11,8.2,2.4,3326|4067|4869|4998|5000|7314|7529|7534|10388|79184|92421,HSP90AB1|LYN|NPM1|ORC1|ORC4|UBB|YWHAB|YWHAZ|SYCP2|BRCC3|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:1902750,negative regulation of cell cycle G2/M phase transition,19_GO:0048519 negative regulation of biological process,-3.6,13,6.7,30286,70,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:0030335,positive regulation of cell migration,19_GO:0040011 locomotion,-3.6,3.9,4.7,30286,580,134,10,7.5,2.3,71|2246|2321|4067|5354|7010|9037|27329|57142|64805,ACTG1|FGF1|FLT1|LYN|PLP1|TEK|SEMA5A|ANGPTL3|RTN4|P2RY12,-1.1,Ccdc115
GO Biological Processes,19,GO:0070536,protein K63-linked deubiquitination,19_GO:0008152 metabolic process,-3.5,23,8,30286,29,134,3,2.2,1.3,1540|79184|373509,CYLD|BRCC3|USP50,-1.1,Ccdc115
Reactome Gene Sets,6,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,,-3.5,5.6,5.1,30286,285,134,7,5.2,1.9,3184|3187|4809|5094|23283|51691|220988,HNRNPD|HNRNPH1|SNU13|PCBP2|CSTF2T|LSM8|HNRNPA3,-1.1,Ccdc115
GO Biological Processes,19,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,19_GO:0048518 positive regulation of biological process,-3.5,8.7,5.9,30286,130,134,5,3.7,1.6,4869|7314|7337|8452|55743,NPM1|UBB|UBE3A|CUL3|CHFR,-1.1,Ccdc115
Reactome Gene Sets,6,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,,-3.5,13,6.5,30286,72,134,4,3,1.5,71|808|7529|7534,ACTG1|CALM3|YWHAB|YWHAZ,-1.1,Ccdc115
KEGG Pathway,24,hsa04114,Oocyte meiosis,,-3.5,8.6,5.8,30286,131,134,5,3.7,1.6,367|808|5532|7529|7534,AR|CALM3|PPP3CB|YWHAB|YWHAZ,-1.1,Ccdc115
GO Biological Processes,19,GO:1901875,positive regulation of post-translational protein modification,19_GO:0048518 positive regulation of biological process,-3.5,8.6,5.8,30286,131,134,5,3.7,1.6,4869|7314|7337|8452|55743,NPM1|UBB|UBE3A|CUL3|CHFR,-1.1,Ccdc115
Reactome Gene Sets,6,R-HSA-5654738,Signaling by FGFR2,,-3.5,12,6.5,30286,73,134,4,3,1.5,2246|2263|3187|7314,FGF1|FGFR2|HNRNPH1|UBB,-1.1,Ccdc115
GO Biological Processes,19,GO:0031348,negative regulation of defense response,19_GO:0048519 negative regulation of biological process,-3.5,5.4,5.1,30286,291,134,7,5.2,1.9,1540|4067|4907|5094|5734|7010|7534,CYLD|LYN|NT5E|PCBP2|PTGER4|TEK|YWHAZ,-1.1,Ccdc115
Reactome Gene Sets,6,R-HSA-72163,mRNA Splicing - Major Pathway,,-3.5,6.6,5.3,30286,207,134,6,4.5,1.8,3184|3187|4809|5094|51691|220988,HNRNPD|HNRNPH1|SNU13|PCBP2|LSM8|HNRNPA3,-1.1,Ccdc115
GO Biological Processes,19,GO:0030163,protein catabolic process,19_GO:0008152 metabolic process,-3.5,3.5,4.5,30286,711,134,11,8.2,2.4,5094|7314|7337|8452|10973|27429|29978|55743|57531|64320|92421,PCBP2|UBB|UBE3A|CUL3|ASCC3|HTRA2|UBQLN2|CHFR|HACE1|RNF25|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:0071363,cellular response to growth factor stimulus,19_GO:0050896 response to stimulus,-3.5,4.2,4.7,30286,488,134,9,6.7,2.2,285|658|2246|2263|2321|7337|23767|27429|91851,ANGPT2|BMPR1B|FGF1|FGFR2|FLT1|UBE3A|FLRT3|HTRA2|CHRDL1,-1.1,Ccdc115
GO Biological Processes,19,GO:0019941,modification-dependent protein catabolic process,19_GO:0008152 metabolic process,-3.5,4.2,4.7,30286,489,134,9,6.7,2.2,5094|7314|7337|8452|10973|55743|57531|64320|92421,PCBP2|UBB|UBE3A|CUL3|ASCC3|CHFR|HACE1|RNF25|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:0051603,proteolysis involved in protein catabolic process,19_GO:0008152 metabolic process,-3.5,3.8,4.6,30286,598,134,10,7.5,2.3,5094|7314|7337|8452|10973|29978|55743|57531|64320|92421,PCBP2|UBB|UBE3A|CUL3|ASCC3|UBQLN2|CHFR|HACE1|RNF25|CHMP4C,-1.1,Ccdc115
GO Biological Processes,19,GO:0051962,positive regulation of nervous system development,19_GO:0032502 developmental process,-3.5,5.4,5,30286,294,134,7,5.2,1.9,443|4067|4747|4988|9037|23767|347730,ASPA|LYN|NEFL|OPRM1|SEMA5A|FLRT3|LRRTM1,-1.1,Ccdc115
GO Biological Processes,19,GO:2000242,negative regulation of reproductive process,19_GO:0022414 reproductive process,-3.4,12,6.3,30286,76,134,4,3,1.5,10388|27306|55743|55840,SYCP2|HPGDS|CHFR|EAF2,-1,Ccdc115
GO Biological Processes,19,GO:0060560,developmental growth involved in morphogenesis,19_GO:0040007 growth,-3.4,8.2,5.7,30286,137,134,5,3.7,1.6,2246|2263|5532|9037|23767,FGF1|FGFR2|PPP3CB|SEMA5A|FLRT3,-1,Ccdc115
GO Biological Processes,19,GO:0048608,reproductive structure development,19_GO:0022414 reproductive process,-3.4,5.3,5,30286,297,134,7,5.2,1.9,367|658|2263|7314|7337|10388|55840,AR|BMPR1B|FGFR2|UBB|UBE3A|SYCP2|EAF2,-1,Ccdc115
GO Biological Processes,19,GO:0032989,cellular anatomical entity morphogenesis,19_GO:0032502 developmental process,-3.4,3.7,4.5,30286,605,134,10,7.5,2.3,71|658|2263|2823|4747|5532|7314|8633|9037|23767,ACTG1|BMPR1B|FGFR2|GPM6A|NEFL|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-5357801,Programmed Cell Death,,-3.4,6.4,5.2,30286,213,134,6,4.5,1.8,1687|3006|7314|7529|7534|92421,GSDME|H1-2|UBB|YWHAB|YWHAZ|CHMP4C,-1,Ccdc115
GO Biological Processes,19,GO:2000147,positive regulation of cell motility,19_GO:0040011 locomotion,-3.4,3.7,4.5,30286,607,134,10,7.5,2.3,71|2246|2321|4067|5354|7010|9037|27329|57142|64805,ACTG1|FGF1|FLT1|LYN|PLP1|TEK|SEMA5A|ANGPTL3|RTN4|P2RY12,-1,Ccdc115
GO Biological Processes,19,GO:2000241,regulation of reproductive process,19_GO:0022414 reproductive process,-3.4,6.3,5.2,30286,214,134,6,4.5,1.8,367|8633|10388|27306|55743|55840,AR|UNC5C|SYCP2|HPGDS|CHFR|EAF2,-1,Ccdc115
KEGG Pathway,24,hsa05418,Fluid shear stress and atherosclerosis,,-3.4,8.1,5.6,30286,139,134,5,3.7,1.6,71|658|808|3326|6613,ACTG1|BMPR1B|CALM3|HSP90AB1|SUMO2,-1,Ccdc115
GO Biological Processes,19,GO:0061458,reproductive system development,19_GO:0032502 developmental process,-3.4,5.3,4.9,30286,301,134,7,5.2,1.9,367|658|2263|7314|7337|10388|55840,AR|BMPR1B|FGFR2|UBB|UBE3A|SYCP2|EAF2,-1,Ccdc115
GO Biological Processes,19,GO:0043632,modification-dependent macromolecule catabolic process,19_GO:0008152 metabolic process,-3.4,4.1,4.6,30286,500,134,9,6.7,2.2,5094|7314|7337|8452|10973|55743|57531|64320|92421,PCBP2|UBB|UBE3A|CUL3|ASCC3|CHFR|HACE1|RNF25|CHMP4C,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-72172,mRNA Splicing,,-3.4,6.3,5.2,30286,215,134,6,4.5,1.8,3184|3187|4809|5094|51691|220988,HNRNPD|HNRNPH1|SNU13|PCBP2|LSM8|HNRNPA3,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-2871809,FCERI mediated Ca+2 mobilization,,-3.4,21,7.5,30286,33,134,3,2.2,1.3,808|4067|5532,CALM3|LYN|PPP3CB,-1,Ccdc115
GO Biological Processes,19,GO:0044089,positive regulation of cellular component biogenesis,19_GO:0048518 positive regulation of biological process,-3.4,4,4.6,30286,507,134,9,6.7,2.2,2823|3567|7010|23767|64805|79184|246175|347730|373509,GPM6A|IL5|TEK|FLRT3|P2RY12|BRCC3|CNOT6L|LRRTM1|USP50,-1,Ccdc115
GO Biological Processes,19,GO:2001235,positive regulation of apoptotic signaling pathway,19_GO:0048518 positive regulation of biological process,-3.3,7.9,5.5,30286,143,134,5,3.7,1.6,658|1540|1687|7314|27429,BMPR1B|CYLD|GSDME|UBB|HTRA2,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-5621481,C-type lectin receptors (CLRs),,-3.3,7.9,5.5,30286,143,134,5,3.7,1.6,808|4067|5532|7314|143662,CALM3|LYN|PPP3CB|UBB|MUC15,-1,Ccdc115
GO Biological Processes,19,GO:0040017,positive regulation of locomotion,19_GO:0040011 locomotion,-3.3,3.6,4.4,30286,621,134,10,7.5,2.3,71|2246|2321|4067|5354|7010|9037|27329|57142|64805,ACTG1|FGF1|FLT1|LYN|PLP1|TEK|SEMA5A|ANGPTL3|RTN4|P2RY12,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-5654727,Negative regulation of FGFR2 signaling,,-3.3,20,7.4,30286,34,134,3,2.2,1.3,2246|2263|7314,FGF1|FGFR2|UBB,-1,Ccdc115
GO Biological Processes,19,GO:0070372,regulation of ERK1 and ERK2 cascade,19_GO:0050896 response to stimulus,-3.3,5.1,4.9,30286,308,134,7,5.2,1.9,2246|2263|3357|4067|4988|7010|7534,FGF1|FGFR2|HTR2B|LYN|OPRM1|TEK|YWHAZ,-1,Ccdc115
GO Biological Processes,19,GO:0030900,forebrain development,19_GO:0032502 developmental process,-3.3,4.4,4.7,30286,407,134,8,6,2,2263|4747|7314|9037|27429|57142|64805|93986,FGFR2|NEFL|UBB|SEMA5A|HTRA2|RTN4|P2RY12|FOXP2,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,,-3.3,11,6.1,30286,82,134,4,3,1.5,1540|3326|5094|7314,CYLD|HSP90AB1|PCBP2|UBB,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,,-3.3,19,7.3,30286,35,134,3,2.2,1.3,1540|5094|7314,CYLD|PCBP2|UBB,-1,Ccdc115
Reactome Gene Sets,6,R-HSA-9706574,RHOBTB GTPase Cycle,,-3.3,19,7.3,30286,35,134,3,2.2,1.3,71|3326|8452,ACTG1|HSP90AB1|CUL3,-1,Ccdc115
GO Biological Processes,19,GO:0070848,response to growth factor,19_GO:0050896 response to stimulus,-3.3,3.9,4.5,30286,520,134,9,6.7,2.2,285|658|2246|2263|2321|7337|23767|27429|91851,ANGPT2|BMPR1B|FGF1|FGFR2|FLT1|UBE3A|FLRT3|HTRA2|CHRDL1,-0.98,Ccdc115
Reactome Gene Sets,6,R-HSA-9679506,SARS-CoV Infections,,-3.3,4.4,4.6,30286,414,134,8,6,2,3326|4869|5094|7314|7529|7534|8452|92421,HSP90AB1|NPM1|PCBP2|UBB|YWHAB|YWHAZ|CUL3|CHMP4C,-0.98,Ccdc115
Reactome Gene Sets,6,R-HSA-388396,GPCR downstream signalling,,-3.3,3.6,4.4,30286,634,134,10,7.5,2.3,808|3357|4988|5532|5734|6019|9934|10803|10846|64805,CALM3|HTR2B|OPRM1|PPP3CB|PTGER4|RLN2|P2RY14|CCR9|PDE10A|P2RY12,-0.98,Ccdc115
Reactome Gene Sets,6,R-HSA-199991,Membrane Trafficking,,-3.3,3.6,4.4,30286,634,134,10,7.5,2.3,71|808|830|7314|7529|7534|23682|29978|60592|92421,ACTG1|CALM3|CAPZA2|UBB|YWHAB|YWHAZ|RAB38|UBQLN2|SCOC|CHMP4C,-0.98,Ccdc115
GO Biological Processes,19,GO:1903050,regulation of proteolysis involved in protein catabolic process,19_GO:0008152 metabolic process,-3.3,5.9,5,30286,228,134,6,4.5,1.8,3326|6613|7314|7337|29978|55743,HSP90AB1|SUMO2|UBB|UBE3A|UBQLN2|CHFR,-0.97,Ccdc115
GO Biological Processes,19,GO:0048589,developmental growth,19_GO:0040007 growth,-3.2,4.3,4.5,30286,424,134,8,6,2,367|658|2246|2263|5532|7337|9037|23767,AR|BMPR1B|FGF1|FGFR2|PPP3CB|UBE3A|SEMA5A|FLRT3,-0.93,Ccdc115
GO Biological Processes,19,GO:0040007,growth,19_GO:0040007 growth,-3.2,4.3,4.5,30286,424,134,8,6,2,367|658|2246|2263|5532|7337|9037|23767,AR|BMPR1B|FGF1|FGFR2|PPP3CB|UBE3A|SEMA5A|FLRT3,-0.93,Ccdc115
Reactome Gene Sets,6,R-HSA-1280218,Adaptive Immune System,,-3.2,3.2,4.2,30286,768,134,11,8.2,2.4,808|830|4067|5532|7314|7337|7529|7534|8452|57531|64320,CALM3|CAPZA2|LYN|PPP3CB|UBB|UBE3A|YWHAB|YWHAZ|CUL3|HACE1|RNF25,-0.92,Ccdc115
Reactome Gene Sets,6,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,,-3.2,10,5.8,30286,88,134,4,3,1.5,3184|7314|7529|7534,HNRNPD|UBB|YWHAB|YWHAZ,-0.92,Ccdc115
KEGG Pathway,24,hsa04014,Ras signaling pathway,,-3.2,5.7,4.9,30286,236,134,6,4.5,1.8,285|808|2246|2263|2321|7010,ANGPT2|CALM3|FGF1|FGFR2|FLT1|TEK,-0.92,Ccdc115
GO Biological Processes,19,GO:0007143,female meiotic nuclear division,19_GO:0022414 reproductive process,-3.2,17,6.8,30286,39,134,3,2.2,1.3,5000|7314|10388,ORC4|UBB|SYCP2,-0.9,Ccdc115
GO Biological Processes,19,GO:0048514,blood vessel morphogenesis,19_GO:0032502 developmental process,-3.2,4.2,4.5,30286,431,134,8,6,2,71|285|2246|2263|2321|7010|9037|27329,ACTG1|ANGPT2|FGF1|FGFR2|FLT1|TEK|SEMA5A|ANGPTL3,-0.9,Ccdc115
Reactome Gene Sets,6,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),,-3.1,4.7,4.6,30286,334,134,7,5.2,1.9,3357|4988|5734|6019|9934|10803|64805,HTR2B|OPRM1|PTGER4|RLN2|P2RY14|CCR9|P2RY12,-0.88,Ccdc115
GO Biological Processes,19,GO:0001944,vasculature development,19_GO:0032502 developmental process,-3.1,3.7,4.3,30286,547,134,9,6.7,2.2,71|285|2246|2263|2321|5532|7010|9037|27329,ACTG1|ANGPT2|FGF1|FGFR2|FLT1|PPP3CB|TEK|SEMA5A|ANGPTL3,-0.87,Ccdc115
GO Biological Processes,19,GO:0050807,regulation of synapse organization,19_GO:0050789 regulation of biological process,-3.1,5.6,4.8,30286,243,134,6,4.5,1.8,2823|4747|7337|7534|23767|347730,GPM6A|NEFL|UBE3A|YWHAZ|FLRT3|LRRTM1,-0.87,Ccdc115
GO Biological Processes,19,GO:0009266,response to temperature stimulus,19_GO:0050896 response to stimulus,-3.1,7,5.1,30286,161,134,5,3.7,1.6,2246|3326|3357|4067|27429,FGF1|HSP90AB1|HTR2B|LYN|HTRA2,-0.87,Ccdc115
GO Biological Processes,19,GO:0009408,response to heat,19_GO:0050896 response to stimulus,-3.1,9.7,5.6,30286,93,134,4,3,1.5,2246|3326|4067|27429,FGF1|HSP90AB1|LYN|HTRA2,-0.87,Ccdc115
GO Biological Processes,19,GO:0048667,cell morphogenesis involved in neuron differentiation,19_GO:0032502 developmental process,-3.1,4.1,4.4,30286,440,134,8,6,2,71|658|2263|4747|5532|8633|9037|23767,ACTG1|BMPR1B|FGFR2|NEFL|PPP3CB|UNC5C|SEMA5A|FLRT3,-0.87,Ccdc115
GO Biological Processes,19,GO:0008285,negative regulation of cell population proliferation,19_GO:0048519 negative regulation of biological process,-3.1,3.1,4.1,30286,791,134,11,8.2,2.4,367|658|1687|2263|2321|4067|4869|4988|26136|27306|55840,AR|BMPR1B|GSDME|FGFR2|FLT1|LYN|NPM1|OPRM1|TES|HPGDS|EAF2,-0.86,Ccdc115
GO Biological Processes,19,GO:0051781,positive regulation of cell division,19_GO:0048518 positive regulation of biological process,-3.1,9.6,5.6,30286,94,134,4,3,1.5,2246|2263|3357|8452,FGF1|FGFR2|HTR2B|CUL3,-0.86,Ccdc115
Reactome Gene Sets,6,R-HSA-9824443,Parasitic Infection Pathways,,-3.1,6.9,5,30286,164,134,5,3.7,1.6,71|808|3326|4067|4907,ACTG1|CALM3|HSP90AB1|LYN|NT5E,-0.86,Ccdc115
Reactome Gene Sets,6,R-HSA-9658195,Leishmania infection,,-3.1,6.9,5,30286,164,134,5,3.7,1.6,71|808|3326|4067|4907,ACTG1|CALM3|HSP90AB1|LYN|NT5E,-0.86,Ccdc115
Reactome Gene Sets,6,R-HSA-5653656,Vesicle-mediated transport,,-3.1,3.4,4.1,30286,673,134,10,7.5,2.3,71|808|830|7314|7529|7534|23682|29978|60592|92421,ACTG1|CALM3|CAPZA2|UBB|YWHAB|YWHAZ|RAB38|UBQLN2|SCOC|CHMP4C,-0.85,Ccdc115
Canonical Pathways,11,M5883,NABA SECRETED FACTORS,,-3.1,4.6,4.5,30286,343,134,7,5.2,1.9,285|2246|3567|9068|23452|27329|91851,ANGPT2|FGF1|IL5|ANGPTL1|ANGPTL2|ANGPTL3|CHRDL1,-0.85,Ccdc115
GO Biological Processes,19,GO:0050803,regulation of synapse structure or activity,19_GO:0065007 biological regulation,-3.1,5.4,4.7,30286,249,134,6,4.5,1.8,2823|4747|7337|7534|23767|347730,GPM6A|NEFL|UBE3A|YWHAZ|FLRT3|LRRTM1,-0.85,Ccdc115
GO Biological Processes,19,GO:0031344,regulation of cell projection organization,19_GO:0050789 regulation of biological process,-3.1,3.3,4.1,30286,676,134,10,7.5,2.3,1540|2823|4067|4747|7337|9037|57142|64805|128344|347240,CYLD|GPM6A|LYN|NEFL|UBE3A|SEMA5A|RTN4|P2RY12|CIMAP3|KIF24,-0.85,Ccdc115
GO Biological Processes,19,GO:0062207,regulation of pattern recognition receptor signaling pathway,19_GO:0044419 biological process involved in interspecies interaction between organisms,-3.1,6.8,5,30286,166,134,5,3.7,1.6,4067|5094|57142|79184|373509,LYN|PCBP2|RTN4|BRCC3|USP50,-0.85,Ccdc115
GO Biological Processes,19,GO:0000209,protein polyubiquitination,19_GO:0008152 metabolic process,-3.1,5.4,4.7,30286,250,134,6,4.5,1.8,7337|8452|10758|55743|57531|64320,UBE3A|CUL3|TRAF3IP2|CHFR|HACE1|RNF25,-0.85,Ccdc115
GO Biological Processes,19,GO:0010518,positive regulation of phospholipase activity,19_GO:0065007 biological regulation,-3,16,6.5,30286,43,134,3,2.2,1.3,2263|2321|3357,FGFR2|FLT1|HTR2B,-0.84,Ccdc115
Reactome Gene Sets,6,R-HSA-9656223,Signaling by RAF1 mutants,,-3,16,6.5,30286,43,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.84,Ccdc115
GO Biological Processes,19,GO:1903312,negative regulation of mRNA metabolic process,19_GO:0048519 negative regulation of biological process,-3,9.3,5.5,30286,97,134,4,3,1.5,3184|4869|10758|169966,HNRNPD|NPM1|TRAF3IP2|TENT5D,-0.84,Ccdc115
KEGG Pathway,24,hsa04020,Calcium signaling pathway,,-3,5.4,4.6,30286,253,134,6,4.5,1.8,808|2246|2263|2321|3357|5532,CALM3|FGF1|FGFR2|FLT1|HTR2B|PPP3CB,-0.84,Ccdc115
GO Biological Processes,19,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,19_GO:0050896 response to stimulus,-3,5.4,4.6,30286,253,134,6,4.5,1.8,2321|7010|7337|9037|57142|64805,FLT1|TEK|UBE3A|SEMA5A|RTN4|P2RY12,-0.84,Ccdc115
GO Biological Processes,19,GO:0019725,cellular homeostasis,19_GO:0042592 homeostatic process,-3,3.3,4.1,30286,683,134,10,7.5,2.3,212|226|3357|4869|7337|23682|51714|57142|84899|283652,ALAS2|ALDOA|HTR2B|NPM1|UBE3A|RAB38|SELENOT|RTN4|TMTC4|SLC24A5,-0.84,Ccdc115
GO Biological Processes,19,GO:0030097,hemopoiesis,19_GO:0032502 developmental process,-3,3.3,4.1,30286,683,134,10,7.5,2.3,212|1540|2124|2263|4067|5532|5734|7010|10758|10803,ALAS2|CYLD|EVI2B|FGFR2|LYN|PPP3CB|PTGER4|TEK|TRAF3IP2|CCR9,-0.84,Ccdc115
GO Biological Processes,19,GO:0010720,positive regulation of cell development,19_GO:0032502 developmental process,-3,4,4.3,30286,454,134,8,6,2,443|1540|2124|3567|4067|4747|4988|9037,ASPA|CYLD|EVI2B|IL5|LYN|NEFL|OPRM1|SEMA5A,-0.84,Ccdc115
GO Biological Processes,19,GO:0019722,calcium-mediated signaling,19_GO:0050896 response to stimulus,-3,6.6,4.9,30286,171,134,5,3.7,1.6,808|3357|5532|10803|64805,CALM3|HTR2B|PPP3CB|CCR9|P2RY12,-0.82,Ccdc115
GO Biological Processes,19,GO:0045765,regulation of angiogenesis,19_GO:0032502 developmental process,-3,4.5,4.4,30286,353,134,7,5.2,1.9,285|2246|2321|6019|7010|9037|27329,ANGPT2|FGF1|FLT1|RLN2|TEK|SEMA5A|ANGPTL3,-0.82,Ccdc115
Reactome Gene Sets,6,R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,,-3,3.9,4.2,30286,459,134,8,6,2,71|808|2246|2263|4067|4869|7314|7529,ACTG1|CALM3|FGF1|FGFR2|LYN|NPM1|UBB|YWHAB,-0.82,Ccdc115
GO Biological Processes,19,GO:0097305,response to alcohol,19_GO:0050896 response to stimulus,-3,5.3,4.6,30286,258,134,6,4.5,1.8,2263|2742|3184|4747|4988|5734,FGFR2|GLRA2|HNRNPD|NEFL|OPRM1|PTGER4,-0.82,Ccdc115
GO Biological Processes,19,GO:0050919,negative chemotaxis,19_GO:0040011 locomotion,-3,15,6.2,30286,46,134,3,2.2,1.3,8633|9037|23767,UNC5C|SEMA5A|FLRT3,-0.79,Ccdc115
GO Biological Processes,19,GO:0051960,regulation of nervous system development,19_GO:0032502 developmental process,-2.9,3.9,4.2,30286,468,134,8,6,2,443|4067|4747|4988|9037|23767|57142|347730,ASPA|LYN|NEFL|OPRM1|SEMA5A|FLRT3|RTN4|LRRTM1,-0.78,Ccdc115
GO Biological Processes,19,GO:1901342,regulation of vasculature development,19_GO:0032502 developmental process,-2.9,4.4,4.3,30286,362,134,7,5.2,1.9,285|2246|2321|6019|7010|9037|27329,ANGPT2|FGF1|FLT1|RLN2|TEK|SEMA5A|ANGPTL3,-0.78,Ccdc115
Reactome Gene Sets,6,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,,-2.9,14,6.1,30286,47,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.78,Ccdc115
Reactome Gene Sets,6,R-HSA-6802949,Signaling by RAS mutants,,-2.9,14,6.1,30286,47,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.78,Ccdc115
Reactome Gene Sets,6,R-HSA-9649948,Signaling downstream of RAS mutants,,-2.9,14,6.1,30286,47,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.78,Ccdc115
Reactome Gene Sets,6,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,,-2.9,14,6.1,30286,47,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.78,Ccdc115
GO Biological Processes,19,GO:0014003,oligodendrocyte development,19_GO:0032502 developmental process,-2.9,14,6.1,30286,47,134,3,2.2,1.3,443|4067|5354,ASPA|LYN|PLP1,-0.78,Ccdc115
GO Biological Processes,19,GO:0010389,regulation of G2/M transition of mitotic cell cycle,19_GO:0050789 regulation of biological process,-2.9,8.7,5.2,30286,104,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-0.78,Ccdc115
GO Biological Processes,19,GO:0045859,regulation of protein kinase activity,19_GO:0008152 metabolic process,-2.9,3.8,4.1,30286,470,134,8,6,2,808|2246|2321|3326|3357|4067|4869|55450,CALM3|FGF1|FLT1|HSP90AB1|HTR2B|LYN|NPM1|CAMK2N1,-0.78,Ccdc115
Reactome Gene Sets,6,R-HSA-372790,Signaling by GPCR,,-2.9,3.2,3.9,30286,709,134,10,7.5,2.3,808|3357|4988|5532|5734|6019|9934|10803|10846|64805,CALM3|HTR2B|OPRM1|PPP3CB|PTGER4|RLN2|P2RY14|CCR9|PDE10A|P2RY12,-0.77,Ccdc115
GO Biological Processes,19,GO:0040011,locomotion,19_GO:0040011 locomotion,-2.9,4.3,4.3,30286,366,134,7,5.2,1.9,2321|4747|5532|8633|9037|10803|23767,FLT1|NEFL|PPP3CB|UNC5C|SEMA5A|CCR9|FLRT3,-0.77,Ccdc115
Reactome Gene Sets,6,R-HSA-109581,Apoptosis,,-2.9,6.3,4.7,30286,180,134,5,3.7,1.6,1687|3006|7314|7529|7534,GSDME|H1-2|UBB|YWHAB|YWHAZ,-0.77,Ccdc115
GO Biological Processes,19,GO:0043410,positive regulation of MAPK cascade,19_GO:0048518 positive regulation of biological process,-2.9,3.8,4.1,30286,475,134,8,6,2,367|1687|2246|2263|2321|3357|4988|7010,AR|GSDME|FGF1|FGFR2|FLT1|HTR2B|OPRM1|TEK,-0.77,Ccdc115
GO Biological Processes,19,GO:0030217,T cell differentiation,19_GO:0002376 immune system process,-2.9,6.2,4.7,30286,181,134,5,3.7,1.6,1540|5532|5734|10758|10803,CYLD|PPP3CB|PTGER4|TRAF3IP2|CCR9,-0.77,Ccdc115
GO Biological Processes,19,GO:0006511,ubiquitin-dependent protein catabolic process,19_GO:0008152 metabolic process,-2.9,3.8,4.1,30286,479,134,8,6,2,5094|7337|8452|10973|55743|57531|64320|92421,PCBP2|UBE3A|CUL3|ASCC3|CHFR|HACE1|RNF25|CHMP4C,-0.75,Ccdc115
GO Biological Processes,19,GO:0039531,regulation of cytoplasmic pattern recognition receptor signaling pathway,19_GO:0044419 biological process involved in interspecies interaction between organisms,-2.9,8.4,5.1,30286,108,134,4,3,1.5,5094|57142|79184|373509,PCBP2|RTN4|BRCC3|USP50,-0.75,Ccdc115
KEGG Pathway,24,hsa04066,HIF-1 signaling pathway,,-2.9,8.4,5.1,30286,108,134,4,3,1.5,226|285|2321|7010,ALDOA|ANGPT2|FLT1|TEK,-0.75,Ccdc115
GO Biological Processes,19,GO:0046434,organophosphate catabolic process,19_GO:0008152 metabolic process,-2.9,6.1,4.7,30286,184,134,5,3.7,1.6,226|4907|10846|11164|27329,ALDOA|NT5E|PDE10A|NUDT5|ANGPTL3,-0.74,Ccdc115
GO Biological Processes,19,GO:0051345,positive regulation of hydrolase activity,19_GO:0065007 biological regulation,-2.9,3.8,4.1,30286,482,134,8,6,2,808|2263|2321|3326|3357|4067|27429|373509,CALM3|FGFR2|FLT1|HSP90AB1|HTR2B|LYN|HTRA2|USP50,-0.74,Ccdc115
GO Biological Processes,19,GO:0030162,regulation of proteolysis,19_GO:0008152 metabolic process,-2.8,3.4,3.9,30286,600,134,9,6.7,2.2,3326|4067|6613|7314|7337|27429|29978|55743|373509,HSP90AB1|LYN|SUMO2|UBB|UBE3A|HTRA2|UBQLN2|CHFR|USP50,-0.73,Ccdc115
GO Biological Processes,19,GO:0048871,multicellular organismal-level homeostasis,19_GO:0042592 homeostatic process,-2.8,3.4,3.9,30286,603,134,9,6.7,2.2,71|212|1540|4067|4907|5532|7314|10758|64922,ACTG1|ALAS2|CYLD|LYN|NT5E|PPP3CB|UBB|TRAF3IP2|LRRC19,-0.72,Ccdc115
GO Biological Processes,19,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,19_GO:0048518 positive regulation of biological process,-2.8,13,5.9,30286,51,134,3,2.2,1.3,658|1540|27429,BMPR1B|CYLD|HTRA2,-0.72,Ccdc115
GO Biological Processes,19,GO:0048872,homeostasis of number of cells,19_GO:0042592 homeostatic process,-2.8,4.9,4.3,30286,278,134,6,4.5,1.8,212|1540|4067|5532|10758|64922,ALAS2|CYLD|LYN|PPP3CB|TRAF3IP2|LRRC19,-0.72,Ccdc115
GO Biological Processes,19,GO:0061136,regulation of proteasomal protein catabolic process,19_GO:0008152 metabolic process,-2.8,6,4.6,30286,189,134,5,3.7,1.6,3326|6613|7314|29978|55743,HSP90AB1|SUMO2|UBB|UBQLN2|CHFR,-0.71,Ccdc115
Reactome Gene Sets,6,R-HSA-983705,Signaling by the B Cell Receptor (BCR),,-2.8,8.1,5,30286,112,134,4,3,1.5,808|4067|5532|7314,CALM3|LYN|PPP3CB|UBB,-0.71,Ccdc115
Reactome Gene Sets,6,R-HSA-5654736,Signaling by FGFR1,,-2.8,13,5.8,30286,52,134,3,2.2,1.3,2246|7314|23767,FGF1|UBB|FLRT3,-0.7,Ccdc115
GO Biological Processes,19,GO:0051129,negative regulation of cellular component organization,19_GO:0048519 negative regulation of biological process,-2.8,3.1,3.8,30286,733,134,10,7.5,2.3,367|830|4869|5734|7337|9037|29978|57142|347240|347730,AR|CAPZA2|NPM1|PTGER4|UBE3A|SEMA5A|UBQLN2|RTN4|KIF24|LRRTM1,-0.7,Ccdc115
GO Biological Processes,19,GO:1903046,meiotic cell cycle process,19_GO:0022414 reproductive process,-2.8,5.9,4.5,30286,192,134,5,3.7,1.6,5000|7314|10388|54456|55743,ORC4|UBB|SYCP2|MOV10L1|CHFR,-0.7,Ccdc115
GO Biological Processes,19,GO:0044818,mitotic G2/M transition checkpoint,19_GO:0048519 negative regulation of biological process,-2.8,13,5.7,30286,53,134,3,2.2,1.3,4998|55743|79184,ORC1|CHFR|BRCC3,-0.7,Ccdc115
GO Biological Processes,19,GO:0060193,positive regulation of lipase activity,19_GO:0065007 biological regulation,-2.8,13,5.7,30286,53,134,3,2.2,1.3,2263|2321|3357,FGFR2|FLT1|HTR2B,-0.7,Ccdc115
GO Biological Processes,19,GO:0060688,regulation of morphogenesis of a branching structure,19_GO:0032502 developmental process,-2.8,13,5.7,30286,53,134,3,2.2,1.3,367|2263|57142,AR|FGFR2|RTN4,-0.7,Ccdc115
Canonical Pathways,11,M113,PID NFAT 3PATHWAY,,-2.8,13,5.7,30286,53,134,3,2.2,1.3,5532|7529|7534,PPP3CB|YWHAB|YWHAZ,-0.7,Ccdc115
KEGG Pathway,24,hsa05167,Kaposi sarcoma-associated herpesvirus infection,,-2.8,5.8,4.5,30286,194,134,5,3.7,1.6,285|808|4067|5532|7314,ANGPT2|CALM3|LYN|PPP3CB|UBB,-0.68,Ccdc115
GO Biological Processes,19,GO:0009191,ribonucleoside diphosphate catabolic process,19_GO:0008152 metabolic process,-2.7,13,5.7,30286,54,134,3,2.2,1.3,226|4907|11164,ALDOA|NT5E|NUDT5,-0.68,Ccdc115
GO Biological Processes,19,GO:0007610,behavior,19_GO:0032501 multicellular organismal process,-2.7,3.3,3.8,30286,619,134,9,6.7,2.2,3357|4988|5532|7337|8528|27306|27429|55450|347730,HTR2B|OPRM1|PPP3CB|UBE3A|DDO|HPGDS|HTRA2|CAMK2N1|LRRTM1,-0.68,Ccdc115
GO Biological Processes,19,GO:0009566,fertilization,19_GO:0022414 reproductive process,-2.7,5.8,4.5,30286,195,134,5,3.7,1.6,226|367|4809|7337|10388,ALDOA|AR|SNU13|UBE3A|SYCP2,-0.68,Ccdc115
GO Biological Processes,19,GO:0051336,regulation of hydrolase activity,19_GO:0065007 biological regulation,-2.7,3,3.7,30286,746,134,10,7.5,2.3,808|2263|2321|3326|3357|4067|4869|27329|27429|373509,CALM3|FGFR2|FLT1|HSP90AB1|HTR2B|LYN|NPM1|ANGPTL3|HTRA2|USP50,-0.67,Ccdc115
GO Biological Processes,19,GO:0007626,locomotory behavior,19_GO:0032501 multicellular organismal process,-2.7,5.8,4.5,30286,196,134,5,3.7,1.6,5532|7337|27306|27429|347730,PPP3CB|UBE3A|HPGDS|HTRA2|LRRTM1,-0.67,Ccdc115
Reactome Gene Sets,6,R-HSA-109582,Hemostasis,,-2.7,3.3,3.8,30286,622,134,9,6.7,2.2,226|285|808|830|4067|7010|7534|10846|64805,ALDOA|ANGPT2|CALM3|CAPZA2|LYN|TEK|YWHAZ|PDE10A|P2RY12,-0.67,Ccdc115
Reactome Gene Sets,6,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,,-2.7,12,5.6,30286,55,134,3,2.2,1.3,367|830|3326,AR|CAPZA2|HSP90AB1,-0.67,Ccdc115
GO Biological Processes,19,GO:0007140,male meiotic nuclear division,19_GO:0022414 reproductive process,-2.7,12,5.6,30286,55,134,3,2.2,1.3,7314|10388|54456,UBB|SYCP2|MOV10L1,-0.67,Ccdc115
Reactome Gene Sets,6,R-HSA-109606,Intrinsic Pathway for Apoptosis,,-2.7,12,5.6,30286,55,134,3,2.2,1.3,1687|7529|7534,GSDME|YWHAB|YWHAZ,-0.67,Ccdc115
Reactome Gene Sets,6,R-HSA-69620,Cell Cycle Checkpoints,,-2.7,4.6,4.2,30286,292,134,6,4.5,1.8,4998|5000|7314|7529|7534|79184,ORC1|ORC4|UBB|YWHAB|YWHAZ|BRCC3,-0.66,Ccdc115
Hallmark Gene Sets,23,M5926,HALLMARK MYC TARGETS V1,,-2.7,5.7,4.4,30286,200,134,5,3.7,1.6,52|3184|3326|4869|220988,ACP1|HNRNPD|HSP90AB1|NPM1|HNRNPA3,-0.65,Ccdc115
GO Biological Processes,19,GO:0050728,negative regulation of inflammatory response,19_GO:0048519 negative regulation of biological process,-2.7,5.6,4.4,30286,201,134,5,3.7,1.6,1540|4067|4907|5734|7010,CYLD|LYN|NT5E|PTGER4|TEK,-0.64,Ccdc115
GO Biological Processes,19,GO:0008543,fibroblast growth factor receptor signaling pathway,19_GO:0050896 response to stimulus,-2.7,12,5.5,30286,57,134,3,2.2,1.3,2246|2263|23767,FGF1|FGFR2|FLRT3,-0.64,Ccdc115
Reactome Gene Sets,6,R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",,-2.7,12,5.5,30286,57,134,3,2.2,1.3,1540|3326|7314,CYLD|HSP90AB1|UBB,-0.64,Ccdc115
GO Biological Processes,19,GO:0002221,pattern recognition receptor signaling pathway,19_GO:0044419 biological process involved in interspecies interaction between organisms,-2.7,7.5,4.8,30286,121,134,4,3,1.5,1540|4067|64922|92610,CYLD|LYN|LRRC19|TIFA,-0.64,Ccdc115
GO Biological Processes,19,GO:0051301,cell division,19_GO:0009987 cellular process,-2.7,3.5,3.8,30286,517,134,8,6,2,2263|5000|7150|8452|10388|55743|79184|92421,FGFR2|ORC4|TOP1|CUL3|SYCP2|CHFR|BRCC3|CHMP4C,-0.62,Ccdc115
GO Biological Processes,19,GO:0009134,nucleoside diphosphate catabolic process,19_GO:0008152 metabolic process,-2.7,12,5.4,30286,58,134,3,2.2,1.3,226|4907|11164,ALDOA|NT5E|NUDT5,-0.62,Ccdc115
KEGG Pathway,24,hsa04010,MAPK signaling pathway,,-2.7,4.5,4.1,30286,299,134,6,4.5,1.8,285|2246|2263|2321|5532|7010,ANGPT2|FGF1|FGFR2|FLT1|PPP3CB|TEK,-0.62,Ccdc115
GO Biological Processes,19,GO:0045834,positive regulation of lipid metabolic process,19_GO:0048518 positive regulation of biological process,-2.7,7.4,4.7,30286,123,134,4,3,1.5,2246|3357|23682|27329,FGF1|HTR2B|RAB38|ANGPTL3,-0.62,Ccdc115
GO Biological Processes,19,GO:0070588,calcium ion transmembrane transport,19_GO:0051179 localization,-2.6,5.5,4.3,30286,206,134,5,3.7,1.6,2823|3357|4988|27039|283652,GPM6A|HTR2B|OPRM1|PKD2L2|SLC24A5,-0.62,Ccdc115
GO Biological Processes,19,GO:0043200,response to amino acid,19_GO:0050896 response to stimulus,-2.6,7.3,4.7,30286,124,134,4,3,1.5,2742|3184|4067|8452,GLRA2|HNRNPD|LYN|CUL3,-0.62,Ccdc115
GO Biological Processes,19,GO:0006414,translational elongation,19_GO:0008152 metabolic process,-2.6,11,5.4,30286,59,134,3,2.2,1.3,10973|51714|64320,ASCC3|SELENOT|RNF25,-0.61,Ccdc115
GO Biological Processes,19,GO:0051656,establishment of organelle localization,19_GO:0051179 localization,-2.6,3.9,3.9,30286,410,134,7,5.2,1.9,4067|4747|4869|7314|7534|8452|92421,LYN|NEFL|NPM1|UBB|YWHAZ|CUL3|CHMP4C,-0.6,Ccdc115
Reactome Gene Sets,6,R-HSA-5218859,Regulated Necrosis,,-2.6,11,5.3,30286,60,134,3,2.2,1.3,1687|7314|92421,GSDME|UBB|CHMP4C,-0.6,Ccdc115
GO Biological Processes,19,GO:0007093,mitotic cell cycle checkpoint signaling,19_GO:0048519 negative regulation of biological process,-2.6,7.2,4.6,30286,126,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-0.6,Ccdc115
GO Biological Processes,19,GO:0001568,blood vessel development,19_GO:0032502 developmental process,-2.6,3.4,3.8,30286,527,134,8,6,2,71|285|2246|2263|2321|7010|9037|27329,ACTG1|ANGPT2|FGF1|FGFR2|FLT1|TEK|SEMA5A|ANGPTL3,-0.59,Ccdc115
GO Biological Processes,19,GO:0071902,positive regulation of protein serine/threonine kinase activity,19_GO:0048518 positive regulation of biological process,-2.6,7.1,4.6,30286,127,134,4,3,1.5,808|2246|2321|3357,CALM3|FGF1|FLT1|HTR2B,-0.59,Ccdc115
GO Biological Processes,19,GO:0021987,cerebral cortex development,19_GO:0032502 developmental process,-2.6,7.1,4.6,30286,127,134,4,3,1.5,4747|57142|64805|93986,NEFL|RTN4|P2RY12|FOXP2,-0.59,Ccdc115
GO Biological Processes,19,GO:0048255,mRNA stabilization,19_GO:0048519 negative regulation of biological process,-2.6,11,5.3,30286,61,134,3,2.2,1.3,3184|10758|169966,HNRNPD|TRAF3IP2|TENT5D,-0.59,Ccdc115
KEGG Pathway,24,hsa05200,Pathways in cancer,,-2.6,3.4,3.7,30286,531,134,8,6,2,367|808|2246|2263|3326|3567|5734|29119,AR|CALM3|FGF1|FGFR2|HSP90AB1|IL5|PTGER4|CTNNA3,-0.58,Ccdc115
GO Biological Processes,19,GO:0120035,regulation of plasma membrane bounded cell projection organization,19_GO:0050789 regulation of biological process,-2.6,3.1,3.6,30286,659,134,9,6.7,2.2,1540|2823|4067|4747|7337|9037|57142|64805|347240,CYLD|GPM6A|LYN|NEFL|UBE3A|SEMA5A|RTN4|P2RY12|KIF24,-0.56,Ccdc115
GO Biological Processes,19,GO:0070374,positive regulation of ERK1 and ERK2 cascade,19_GO:0048518 positive regulation of biological process,-2.6,5.3,4.2,30286,215,134,5,3.7,1.6,2246|2263|3357|4988|7010,FGF1|FGFR2|HTR2B|OPRM1|TEK,-0.56,Ccdc115
GO Biological Processes,19,GO:1901654,response to ketone,19_GO:0050896 response to stimulus,-2.6,5.3,4.2,30286,215,134,5,3.7,1.6,367|3184|4747|5734|7337,AR|HNRNPD|NEFL|PTGER4|UBE3A,-0.56,Ccdc115
GO Biological Processes,19,GO:1901292,nucleoside phosphate catabolic process,19_GO:0008152 metabolic process,-2.5,6.8,4.5,30286,132,134,4,3,1.5,226|4907|10846|11164,ALDOA|NT5E|PDE10A|NUDT5,-0.54,Ccdc115
GO Biological Processes,19,GO:0034109,homotypic cell-cell adhesion,19_GO:0009987 cellular process,-2.5,11,5.1,30286,64,134,3,2.2,1.3,71|29119|64805,ACTG1|CTNNA3|P2RY12,-0.54,Ccdc115
GO Biological Processes,19,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,19_GO:0044419 biological process involved in interspecies interaction between organisms,-2.5,11,5.1,30286,64,134,3,2.2,1.3,57142|79184|373509,RTN4|BRCC3|USP50,-0.54,Ccdc115
GO Biological Processes,19,GO:0050727,regulation of inflammatory response,19_GO:0050896 response to stimulus,-2.5,3.7,3.8,30286,425,134,7,5.2,1.9,1540|4067|4907|5734|7010|55450|64922,CYLD|LYN|NT5E|PTGER4|TEK|CAMK2N1|LRRC19,-0.54,Ccdc115
GO Biological Processes,19,GO:0051640,organelle localization,19_GO:0051179 localization,-2.5,3.3,3.7,30286,542,134,8,6,2,4067|4747|4869|7314|7534|8452|92421|415117,LYN|NEFL|NPM1|UBB|YWHAZ|CUL3|CHMP4C|STX19,-0.54,Ccdc115
GO Biological Processes,19,GO:0009611,response to wounding,19_GO:0050896 response to stimulus,-2.5,3.7,3.8,30286,426,134,7,5.2,1.9,71|2246|4067|4747|23767|64805|92421,ACTG1|FGF1|LYN|NEFL|FLRT3|P2RY12|CHMP4C,-0.54,Ccdc115
Reactome Gene Sets,6,R-HSA-418594,G alpha (i) signalling events,,-2.5,4.3,3.9,30286,318,134,6,4.5,1.8,808|4988|5532|9934|10803|64805,CALM3|OPRM1|PPP3CB|P2RY14|CCR9|P2RY12,-0.54,Ccdc115
Reactome Gene Sets,6,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,,-2.5,6.7,4.4,30286,134,134,4,3,1.5,808|4067|5532|7314,CALM3|LYN|PPP3CB|UBB,-0.54,Ccdc115
GO Biological Processes,19,GO:0043405,regulation of MAP kinase activity,19_GO:0008152 metabolic process,-2.5,6.7,4.4,30286,134,134,4,3,1.5,2246|2321|3357|4067,FGF1|FLT1|HTR2B|LYN,-0.54,Ccdc115
GO Biological Processes,19,GO:0018108,peptidyl-tyrosine phosphorylation,19_GO:0008152 metabolic process,-2.5,10,5.1,30286,65,134,3,2.2,1.3,2263|2321|4067,FGFR2|FLT1|LYN,-0.54,Ccdc115
GO Biological Processes,19,GO:0000280,nuclear division,19_GO:0009987 cellular process,-2.5,4.2,3.9,30286,320,134,6,4.5,1.8,5000|7314|8452|10388|54456|92421,ORC4|UBB|CUL3|SYCP2|MOV10L1|CHMP4C,-0.53,Ccdc115
Reactome Gene Sets,6,R-HSA-422475,Axon guidance,,-2.5,3.3,3.6,30286,548,134,8,6,2,71|3326|4067|5532|7314|8633|9037|23767,ACTG1|HSP90AB1|LYN|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-0.53,Ccdc115
Canonical Pathways,11,M255,PID HIF1 TFPATHWAY,,-2.5,10,5,30286,66,134,3,2.2,1.3,226|4869|4907,ALDOA|NPM1|NT5E,-0.52,Ccdc115
KEGG Pathway,24,hsa04915,Estrogen signaling pathway,,-2.5,6.6,4.4,30286,137,134,4,3,1.5,808|3326|3858|4988,CALM3|HSP90AB1|KRT10|OPRM1,-0.51,Ccdc115
GO Biological Processes,19,GO:0048857,neural nucleus development,19_GO:0032502 developmental process,-2.5,10,5,30286,67,134,3,2.2,1.3,808|5354|93986,CALM3|PLP1|FOXP2,-0.51,Ccdc115
Reactome Gene Sets,6,R-HSA-6802952,Signaling by BRAF and RAF1 fusions,,-2.5,10,5,30286,67,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.51,Ccdc115
GO Biological Processes,19,GO:0018212,peptidyl-tyrosine modification,19_GO:0008152 metabolic process,-2.5,10,5,30286,67,134,3,2.2,1.3,2263|2321|4067,FGFR2|FLT1|LYN,-0.51,Ccdc115
GO Biological Processes,19,GO:0035239,tube morphogenesis,19_GO:0032502 developmental process,-2.5,3,3.5,30286,682,134,9,6.7,2.2,71|285|367|2246|2263|2321|7010|9037|27329,ACTG1|ANGPT2|AR|FGF1|FGFR2|FLT1|TEK|SEMA5A|ANGPTL3,-0.5,Ccdc115
GO Biological Processes,19,GO:0071300,cellular response to retinoic acid,19_GO:0050896 response to stimulus,-2.5,10,4.9,30286,68,134,3,2.2,1.3,2263|4067|27429,FGFR2|LYN|HTRA2,-0.5,Ccdc115
GO Biological Processes,19,GO:0001101,response to acid chemical,19_GO:0050896 response to stimulus,-2.5,6.5,4.3,30286,139,134,4,3,1.5,2742|3184|4067|8452,GLRA2|HNRNPD|LYN|CUL3,-0.5,Ccdc115
GO Biological Processes,19,GO:0002260,lymphocyte homeostasis,19_GO:0042592 homeostatic process,-2.4,9.8,4.9,30286,69,134,3,2.2,1.3,4067|5532|10758,LYN|PPP3CB|TRAF3IP2,-0.49,Ccdc115
KEGG Pathway,24,hsa04924,Renin secretion,,-2.4,9.8,4.9,30286,69,134,3,2.2,1.3,808|5532|5734,CALM3|PPP3CB|PTGER4,-0.49,Ccdc115
GO Biological Processes,19,GO:0050920,regulation of chemotaxis,19_GO:0040011 locomotion,-2.4,4.9,4,30286,229,134,5,3.7,1.6,285|2246|4067|9037|64805,ANGPT2|FGF1|LYN|SEMA5A|P2RY12,-0.49,Ccdc115
GO Biological Processes,19,GO:1903131,mononuclear cell differentiation,19_GO:0032502 developmental process,-2.4,4.1,3.8,30286,331,134,6,4.5,1.8,1540|4067|5532|5734|10758|10803,CYLD|LYN|PPP3CB|PTGER4|TRAF3IP2|CCR9,-0.49,Ccdc115
GO Biological Processes,19,GO:0034655,nucleobase-containing compound catabolic process,19_GO:0008152 metabolic process,-2.4,4.1,3.8,30286,332,134,6,4.5,1.8,226|3184|4907|10846|11164|246175,ALDOA|HNRNPD|NT5E|PDE10A|NUDT5|CNOT6L,-0.48,Ccdc115
GO Biological Processes,19,GO:0002758,innate immune response-activating signaling pathway,19_GO:0044419 biological process involved in interspecies interaction between organisms,-2.4,6.4,4.3,30286,142,134,4,3,1.5,1540|4067|64922|92610,CYLD|LYN|LRRC19|TIFA,-0.48,Ccdc115
GO Biological Processes,19,GO:0043489,RNA stabilization,19_GO:0048519 negative regulation of biological process,-2.4,9.7,4.9,30286,70,134,3,2.2,1.3,3184|10758|169966,HNRNPD|TRAF3IP2|TENT5D,-0.48,Ccdc115
Reactome Gene Sets,6,R-HSA-68949,Orc1 removal from chromatin,,-2.4,9.5,4.8,30286,71,134,3,2.2,1.3,4998|5000|7314,ORC1|ORC4|UBB,-0.46,Ccdc115
GO Biological Processes,19,GO:0045862,positive regulation of proteolysis,19_GO:0048518 positive regulation of biological process,-2.4,4,3.7,30286,336,134,6,4.5,1.8,4067|6613|27429|29978|55743|373509,LYN|SUMO2|HTRA2|UBQLN2|CHFR|USP50,-0.46,Ccdc115
GO Biological Processes,19,GO:0007507,heart development,19_GO:0032502 developmental process,-2.4,3.2,3.5,30286,570,134,8,6,2,2263|3357|5532|7010|10758|23767|57142|128344,FGFR2|HTR2B|PPP3CB|TEK|TRAF3IP2|FLRT3|RTN4|CIMAP3,-0.46,Ccdc115
GO Biological Processes,19,GO:0050808,synapse organization,19_GO:0009987 cellular process,-2.4,4,3.7,30286,337,134,6,4.5,1.8,71|2823|4747|23767|91851|347730,ACTG1|GPM6A|NEFL|FLRT3|CHRDL1|LRRTM1,-0.46,Ccdc115
Reactome Gene Sets,6,R-HSA-9675108,Nervous system development,,-2.4,3.2,3.5,30286,573,134,8,6,2,71|3326|4067|5532|7314|8633|9037|23767,ACTG1|HSP90AB1|LYN|PPP3CB|UBB|UNC5C|SEMA5A|FLRT3,-0.45,Ccdc115
GO Biological Processes,19,GO:0055082,intracellular chemical homeostasis,19_GO:0042592 homeostatic process,-2.4,3.1,3.5,30286,575,134,8,6,2,212|3357|7337|23682|51714|57142|84899|283652,ALAS2|HTR2B|UBE3A|RAB38|SELENOT|RTN4|TMTC4|SLC24A5,-0.44,Ccdc115
Reactome Gene Sets,6,R-HSA-9824439,Bacterial Infection Pathways,,-2.4,9.3,4.7,30286,73,134,3,2.2,1.3,808|3326|7314,CALM3|HSP90AB1|UBB,-0.44,Ccdc115
GO Biological Processes,19,GO:1902373,negative regulation of mRNA catabolic process,19_GO:0048519 negative regulation of biological process,-2.4,9.3,4.7,30286,73,134,3,2.2,1.3,3184|10758|169966,HNRNPD|TRAF3IP2|TENT5D,-0.44,Ccdc115
GO Biological Processes,19,GO:1901987,regulation of cell cycle phase transition,19_GO:0050789 regulation of biological process,-2.4,3.5,3.5,30286,455,134,7,5.2,1.9,4869|4998|8452|55743|79184|92421|373509,NPM1|ORC1|CUL3|CHFR|BRCC3|CHMP4C|USP50,-0.44,Ccdc115
GO Biological Processes,19,GO:0001934,positive regulation of protein phosphorylation,19_GO:0048518 positive regulation of biological process,-2.4,3.1,3.4,30286,578,134,8,6,2,808|2246|2321|3326|3357|3567|4067|7010,CALM3|FGF1|FLT1|HSP90AB1|HTR2B|IL5|LYN|TEK,-0.44,Ccdc115
GO Biological Processes,19,GO:0009636,response to toxic substance,19_GO:0050896 response to stimulus,-2.4,4.7,3.8,30286,240,134,5,3.7,1.6,4067|4747|9963|27429|51714,LYN|NEFL|SLC23A1|HTRA2|SELENOT,-0.43,Ccdc115
Reactome Gene Sets,6,R-HSA-453279,Mitotic G1 phase and G1/S transition,,-2.4,6.1,4.1,30286,149,134,4,3,1.5,4067|4998|5000|7314,LYN|ORC1|ORC4|UBB,-0.43,Ccdc115
GO Biological Processes,19,GO:0048285,organelle fission,19_GO:0009987 cellular process,-2.3,3.9,3.6,30286,346,134,6,4.5,1.8,5000|7314|8452|10388|54456|92421,ORC4|UBB|CUL3|SYCP2|MOV10L1|CHMP4C,-0.42,Ccdc115
GO Biological Processes,19,GO:0009185,ribonucleoside diphosphate metabolic process,19_GO:0008152 metabolic process,-2.3,8.9,4.6,30286,76,134,3,2.2,1.3,226|4907|11164,ALDOA|NT5E|NUDT5,-0.4,Ccdc115
GO Biological Processes,19,GO:0050769,positive regulation of neurogenesis,19_GO:0032502 developmental process,-2.3,4.6,3.8,30286,246,134,5,3.7,1.6,443|4067|4747|4988|9037,ASPA|LYN|NEFL|OPRM1|SEMA5A,-0.39,Ccdc115
GO Biological Processes,19,GO:0070936,protein K48-linked ubiquitination,19_GO:0008152 metabolic process,-2.3,8.8,4.6,30286,77,134,3,2.2,1.3,7337|8452|57531,UBE3A|CUL3|HACE1,-0.39,Ccdc115
GO Biological Processes,19,GO:0016310,phosphorylation,19_GO:0008152 metabolic process,-2.3,2.8,3.3,30286,721,134,9,6.7,2.2,658|2263|2321|3357|4067|5532|7010|7150|7534,BMPR1B|FGFR2|FLT1|HTR2B|LYN|PPP3CB|TEK|TOP1|YWHAZ,-0.39,Ccdc115
Reactome Gene Sets,6,R-HSA-500792,GPCR ligand binding,,-2.3,3.4,3.5,30286,468,134,7,5.2,1.9,3357|4988|5734|6019|9934|10803|64805,HTR2B|OPRM1|PTGER4|RLN2|P2RY14|CCR9|P2RY12,-0.39,Ccdc115
GO Biological Processes,19,GO:0007338,single fertilization,19_GO:0022414 reproductive process,-2.3,5.8,4,30286,155,134,4,3,1.5,226|367|4809|7337,ALDOA|AR|SNU13|UBE3A,-0.38,Ccdc115
GO Biological Processes,19,GO:0035304,regulation of protein dephosphorylation,19_GO:0008152 metabolic process,-2.3,8.6,4.5,30286,79,134,3,2.2,1.3,808|3326|7529,CALM3|HSP90AB1|YWHAB,-0.37,Ccdc115
GO Biological Processes,19,GO:2001236,regulation of extrinsic apoptotic signaling pathway,19_GO:0050896 response to stimulus,-2.3,5.8,4,30286,157,134,4,3,1.5,367|658|1540|27429,AR|BMPR1B|CYLD|HTRA2,-0.37,Ccdc115
KEGG Pathway,24,hsa04110,Cell cycle,,-2.3,5.8,4,30286,157,134,4,3,1.5,4998|5000|7529|7534,ORC1|ORC4|YWHAB|YWHAZ,-0.37,Ccdc115
GO Biological Processes,19,GO:0006816,calcium ion transport,19_GO:0051179 localization,-2.3,4.5,3.7,30286,252,134,5,3.7,1.6,2823|3357|4988|27039|283652,GPM6A|HTR2B|OPRM1|PKD2L2|SLC24A5,-0.36,Ccdc115
GO Biological Processes,19,GO:0007292,female gamete generation,19_GO:0022414 reproductive process,-2.3,5.7,4,30286,158,134,4,3,1.5,658|5000|7314|10388,BMPR1B|ORC4|UBB|SYCP2,-0.36,Ccdc115
GO Biological Processes,19,GO:1990138,neuron projection extension,19_GO:0040007 growth,-2.3,8.5,4.5,30286,80,134,3,2.2,1.3,5532|9037|23767,PPP3CB|SEMA5A|FLRT3,-0.36,Ccdc115
Canonical Pathways,11,M223,PID BETA CATENIN NUC PATHWAY,,-2.3,8.5,4.5,30286,80,134,3,2.2,1.3,367|7529|7534,AR|YWHAB|YWHAZ,-0.36,Ccdc115
GO Biological Processes,19,GO:0051321,meiotic cell cycle,19_GO:0022414 reproductive process,-2.2,4.4,3.7,30286,255,134,5,3.7,1.6,5000|7314|10388|54456|55743,ORC4|UBB|SYCP2|MOV10L1|CHFR,-0.35,Ccdc115
GO Biological Processes,19,GO:0071345,cellular response to cytokine stimulus,19_GO:0050896 response to stimulus,-2.2,2.8,3.2,30286,738,134,9,6.7,2.2,71|1687|3326|3567|4067|10758|10803|27429|92610,ACTG1|GSDME|HSP90AB1|IL5|LYN|TRAF3IP2|CCR9|HTRA2|TIFA,-0.35,Ccdc115
GO Biological Processes,19,GO:0045860,positive regulation of protein kinase activity,19_GO:0048518 positive regulation of biological process,-2.2,4.4,3.7,30286,256,134,5,3.7,1.6,808|2246|2321|3326|3357,CALM3|FGF1|FLT1|HSP90AB1|HTR2B,-0.34,Ccdc115
GO Biological Processes,19,GO:0000075,cell cycle checkpoint signaling,19_GO:0048519 negative regulation of biological process,-2.2,5.6,3.9,30286,161,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-0.34,Ccdc115
GO Biological Processes,19,GO:0043406,positive regulation of MAP kinase activity,19_GO:0048518 positive regulation of biological process,-2.2,8.3,4.4,30286,82,134,3,2.2,1.3,2246|2321|3357,FGF1|FLT1|HTR2B,-0.34,Ccdc115
GO Biological Processes,19,GO:1904427,positive regulation of calcium ion transmembrane transport,19_GO:0051179 localization,-2.2,8.3,4.4,30286,82,134,3,2.2,1.3,808|5354|5532,CALM3|PLP1|PPP3CB,-0.34,Ccdc115
GO Biological Processes,19,GO:0048709,oligodendrocyte differentiation,19_GO:0032502 developmental process,-2.2,8.3,4.4,30286,82,134,3,2.2,1.3,443|4067|5354,ASPA|LYN|PLP1,-0.34,Ccdc115
GO Biological Processes,19,GO:1903829,positive regulation of protein localization,19_GO:0051179 localization,-2.2,3.3,3.4,30286,483,134,7,5.2,1.9,1540|3326|4869|5532|23682|27429|57142,CYLD|HSP90AB1|NPM1|PPP3CB|RAB38|HTRA2|RTN4,-0.34,Ccdc115
KEGG Pathway,24,hsa04080,Neuroactive ligand-receptor interaction,,-2.2,3.7,3.5,30286,367,134,6,4.5,1.8,2742|3357|4988|5734|6019|9934,GLRA2|HTR2B|OPRM1|PTGER4|RLN2|P2RY14,-0.33,Ccdc115
Reactome Gene Sets,6,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),,-2.2,8.2,4.4,30286,83,134,3,2.2,1.3,808|5532|7314,CALM3|PPP3CB|UBB,-0.33,Ccdc115
GO Biological Processes,19,GO:0009132,nucleoside diphosphate metabolic process,19_GO:0008152 metabolic process,-2.2,8.2,4.4,30286,83,134,3,2.2,1.3,226|4907|11164,ALDOA|NT5E|NUDT5,-0.33,Ccdc115
GO Biological Processes,19,GO:0006397,mRNA processing,19_GO:0008152 metabolic process,-2.2,3.2,3.3,30286,488,134,7,5.2,1.9,3187|4809|23283|51691|220988|246175|403314,HNRNPH1|SNU13|CSTF2T|LSM8|HNRNPA3|CNOT6L|APOBEC4,-0.33,Ccdc115
GO Biological Processes,19,GO:0051276,chromosome organization,19_GO:0009987 cellular process,-2.2,3.2,3.3,30286,489,134,7,5.2,1.9,3006|3326|7150|8452|10388|10973|92421,H1-2|HSP90AB1|TOP1|CUL3|SYCP2|ASCC3|CHMP4C,-0.32,Ccdc115
Reactome Gene Sets,6,R-HSA-6802957,Oncogenic MAPK signaling,,-2.2,8.1,4.3,30286,84,134,3,2.2,1.3,71|808|7529,ACTG1|CALM3|YWHAB,-0.32,Ccdc115
Canonical Pathways,11,M5885,NABA MATRISOME ASSOCIATED,,-2.2,2.7,3.2,30286,751,134,9,6.7,2.2,285|2246|3567|9037|9068|23452|27329|91851|143662,ANGPT2|FGF1|IL5|SEMA5A|ANGPTL1|ANGPTL2|ANGPTL3|CHRDL1|MUC15,-0.32,Ccdc115
GO Biological Processes,19,GO:0006468,protein phosphorylation,19_GO:0008152 metabolic process,-2.2,3.2,3.3,30286,491,134,7,5.2,1.9,658|2263|2321|4067|5532|7150|7534,BMPR1B|FGFR2|FLT1|LYN|PPP3CB|TOP1|YWHAZ,-0.32,Ccdc115
Reactome Gene Sets,6,R-HSA-76002,"Platelet activation, signaling and aggregation",,-2.2,4.3,3.6,30286,263,134,5,3.7,1.6,226|808|4067|7534|64805,ALDOA|CALM3|LYN|YWHAZ|P2RY12,-0.32,Ccdc115
GO Biological Processes,19,GO:1902369,negative regulation of RNA catabolic process,19_GO:0048519 negative regulation of biological process,-2.2,8,4.3,30286,85,134,3,2.2,1.3,3184|10758|169966,HNRNPD|TRAF3IP2|TENT5D,-0.32,Ccdc115
GO Biological Processes,19,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,19_GO:0008152 metabolic process,-2.2,5.4,3.8,30286,166,134,4,3,1.5,3326|6613|7337|55743,HSP90AB1|SUMO2|UBE3A|CHFR,-0.32,Ccdc115
GO Biological Processes,19,GO:0044270,cellular nitrogen compound catabolic process,19_GO:0008152 metabolic process,-2.2,3.6,3.4,30286,373,134,6,4.5,1.8,226|3184|4907|10846|11164|246175,ALDOA|HNRNPD|NT5E|PDE10A|NUDT5|CNOT6L,-0.32,Ccdc115
GO Biological Processes,19,GO:0046700,heterocycle catabolic process,19_GO:0008152 metabolic process,-2.2,3.6,3.4,30286,374,134,6,4.5,1.8,226|3184|4907|10846|11164|246175,ALDOA|HNRNPD|NT5E|PDE10A|NUDT5|CNOT6L,-0.31,Ccdc115
GO Biological Processes,19,GO:0002218,activation of innate immune response,19_GO:0044419 biological process involved in interspecies interaction between organisms,-2.2,5.4,3.8,30286,167,134,4,3,1.5,1540|4067|64922|92610,CYLD|LYN|LRRC19|TIFA,-0.31,Ccdc115
Reactome Gene Sets,6,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,,-2.2,7.9,4.3,30286,86,134,3,2.2,1.3,71|3326|4067,ACTG1|HSP90AB1|LYN,-0.31,Ccdc115
GO Biological Processes,19,GO:0071230,cellular response to amino acid stimulus,19_GO:0050896 response to stimulus,-2.2,7.9,4.3,30286,86,134,3,2.2,1.3,2742|3184|8452,GLRA2|HNRNPD|CUL3,-0.31,Ccdc115
GO Biological Processes,19,GO:1903169,regulation of calcium ion transmembrane transport,19_GO:0051179 localization,-2.2,5.4,3.8,30286,168,134,4,3,1.5,808|4067|5354|5532,CALM3|LYN|PLP1|PPP3CB,-0.31,Ccdc115
GO Biological Processes,19,GO:0055080,monoatomic cation homeostasis,19_GO:0042592 homeostatic process,-2.2,3.2,3.3,30286,497,134,7,5.2,1.9,212|3357|4907|7337|23682|84899|283652,ALAS2|HTR2B|NT5E|UBE3A|RAB38|TMTC4|SLC24A5,-0.31,Ccdc115
GO Biological Processes,19,GO:0071900,regulation of protein serine/threonine kinase activity,19_GO:0008152 metabolic process,-2.2,4.2,3.5,30286,267,134,5,3.7,1.6,808|2246|2321|3357|4067,CALM3|FGF1|FLT1|HTR2B|LYN,-0.3,Ccdc115
GO Biological Processes,19,GO:0044344,cellular response to fibroblast growth factor stimulus,19_GO:0050896 response to stimulus,-2.2,7.8,4.2,30286,87,134,3,2.2,1.3,2246|2263|23767,FGF1|FGFR2|FLRT3,-0.3,Ccdc115
GO Biological Processes,19,GO:0043488,regulation of mRNA stability,19_GO:0048519 negative regulation of biological process,-2.2,4.2,3.5,30286,269,134,5,3.7,1.6,3184|4869|10758|169966|246175,HNRNPD|NPM1|TRAF3IP2|TENT5D|CNOT6L,-0.3,Ccdc115
GO Biological Processes,19,GO:0045786,negative regulation of cell cycle,19_GO:0048519 negative regulation of biological process,-2.2,3.6,3.4,30286,380,134,6,4.5,1.8,4869|4998|27429|55743|79184|92421,NPM1|ORC1|HTRA2|CHFR|BRCC3|CHMP4C,-0.3,Ccdc115
GO Biological Processes,19,GO:0046889,positive regulation of lipid biosynthetic process,19_GO:0048518 positive regulation of biological process,-2.2,7.7,4.2,30286,88,134,3,2.2,1.3,2246|3357|23682,FGF1|HTR2B|RAB38,-0.3,Ccdc115
GO Biological Processes,19,GO:0030901,midbrain development,19_GO:0032502 developmental process,-2.2,7.7,4.2,30286,88,134,3,2.2,1.3,808|2263|5354,CALM3|FGFR2|PLP1,-0.3,Ccdc115
GO Biological Processes,19,GO:0140013,meiotic nuclear division,19_GO:0022414 reproductive process,-2.1,5.3,3.7,30286,171,134,4,3,1.5,5000|7314|10388|54456,ORC4|UBB|SYCP2|MOV10L1,-0.29,Ccdc115
GO Biological Processes,19,GO:0010638,positive regulation of organelle organization,19_GO:0048518 positive regulation of biological process,-2.1,3.1,3.2,30286,504,134,7,5.2,1.9,3184|3567|5532|8452|9037|27429|246175,HNRNPD|IL5|PPP3CB|CUL3|SEMA5A|HTRA2|CNOT6L,-0.29,Ccdc115
GO Biological Processes,19,GO:0042063,gliogenesis,19_GO:0032502 developmental process,-2.1,4.2,3.5,30286,272,134,5,3.7,1.6,443|4067|5354|57142|64805,ASPA|LYN|PLP1|RTN4|P2RY12,-0.28,Ccdc115
GO Biological Processes,19,GO:0050680,negative regulation of epithelial cell proliferation,19_GO:0048519 negative regulation of biological process,-2.1,5.2,3.7,30286,173,134,4,3,1.5,367|2263|2321|55840,AR|FGFR2|FLT1|EAF2,-0.28,Ccdc115
GO Biological Processes,19,GO:0050801,monoatomic ion homeostasis,19_GO:0042592 homeostatic process,-2.1,3.1,3.2,30286,507,134,7,5.2,1.9,212|3357|4907|7337|23682|84899|283652,ALAS2|HTR2B|NT5E|UBE3A|RAB38|TMTC4|SLC24A5,-0.28,Ccdc115
GO Biological Processes,19,GO:0048762,mesenchymal cell differentiation,19_GO:0032502 developmental process,-2.1,5.2,3.7,30286,174,134,4,3,1.5,2263|3357|9037|57142,FGFR2|HTR2B|SEMA5A|RTN4,-0.27,Ccdc115
GO Biological Processes,19,GO:0009154,purine ribonucleotide catabolic process,19_GO:0008152 metabolic process,-2.1,7.5,4.1,30286,91,134,3,2.2,1.3,226|4907|10846,ALDOA|NT5E|PDE10A,-0.27,Ccdc115
Reactome Gene Sets,6,R-HSA-69052,Switching of origins to a post-replicative state,,-2.1,7.5,4.1,30286,91,134,3,2.2,1.3,4998|5000|7314,ORC1|ORC4|UBB,-0.27,Ccdc115
Reactome Gene Sets,6,R-HSA-111885,Opioid Signalling,,-2.1,7.4,4.1,30286,92,134,3,2.2,1.3,808|4988|5532,CALM3|OPRM1|PPP3CB,-0.26,Ccdc115
GO Biological Processes,19,GO:0010634,positive regulation of epithelial cell migration,19_GO:0040011 locomotion,-2.1,5.1,3.7,30286,177,134,4,3,1.5,2246|7010|9037|57142,FGF1|TEK|SEMA5A|RTN4,-0.25,Ccdc115
GO Biological Processes,19,GO:0016071,mRNA metabolic process,19_GO:0008152 metabolic process,-2.1,2.8,3.1,30286,645,134,8,6,2,3187|4809|5094|23283|51691|220988|246175|403314,HNRNPH1|SNU13|PCBP2|CSTF2T|LSM8|HNRNPA3|CNOT6L|APOBEC4,-0.25,Ccdc115
GO Biological Processes,19,GO:0050767,regulation of neurogenesis,19_GO:0032502 developmental process,-2.1,3.5,3.3,30286,393,134,6,4.5,1.8,443|4067|4747|4988|9037|57142,ASPA|LYN|NEFL|OPRM1|SEMA5A|RTN4,-0.25,Ccdc115
GO Biological Processes,19,GO:0032465,regulation of cytokinesis,19_GO:0050789 regulation of biological process,-2.1,7.3,4.1,30286,93,134,3,2.2,1.3,808|8452|92421,CALM3|CUL3|CHMP4C,-0.25,Ccdc115
KEGG Pathway,24,hsa04520,Adherens junction,,-2.1,7.3,4.1,30286,93,134,3,2.2,1.3,52|71|29119,ACP1|ACTG1|CTNNA3,-0.25,Ccdc115
GO Biological Processes,19,GO:0008585,female gonad development,19_GO:0022414 reproductive process,-2.1,7.3,4.1,30286,93,134,3,2.2,1.3,658|7314|7337,BMPR1B|UBB|UBE3A,-0.25,Ccdc115
GO Biological Processes,19,GO:1903432,regulation of TORC1 signaling,19_GO:0050896 response to stimulus,-2.1,7.3,4.1,30286,93,134,3,2.2,1.3,7337|7534|8452,UBE3A|YWHAZ|CUL3,-0.25,Ccdc115
GO Biological Processes,19,GO:0019439,aromatic compound catabolic process,19_GO:0008152 metabolic process,-2.1,3.4,3.3,30286,394,134,6,4.5,1.8,226|3184|4907|10846|11164|246175,ALDOA|HNRNPD|NT5E|PDE10A|NUDT5|CNOT6L,-0.25,Ccdc115
GO Biological Processes,19,GO:0007548,sex differentiation,19_GO:0022414 reproductive process,-2.1,4,3.4,30286,281,134,5,3.7,1.6,367|658|7314|7337|10388,AR|BMPR1B|UBB|UBE3A|SYCP2,-0.25,Ccdc115
GO Biological Processes,19,GO:0043487,regulation of RNA stability,19_GO:0008152 metabolic process,-2.1,4,3.4,30286,281,134,5,3.7,1.6,3184|4869|10758|169966|246175,HNRNPD|NPM1|TRAF3IP2|TENT5D|CNOT6L,-0.25,Ccdc115
GO Biological Processes,19,GO:0007229,integrin-mediated signaling pathway,19_GO:0050896 response to stimulus,-2.1,7.2,4,30286,94,134,3,2.2,1.3,8452|9358|27329,CUL3|ITGBL1|ANGPTL3,-0.25,Ccdc115
KEGG Pathway,24,hsa04657,IL-17 signaling pathway,,-2.1,7.2,4,30286,94,134,3,2.2,1.3,3326|3567|10758,HSP90AB1|IL5|TRAF3IP2,-0.25,Ccdc115
Reactome Gene Sets,6,R-HSA-5625740,RHO GTPases activate PKNs,,-2.1,7.2,4,30286,94,134,3,2.2,1.3,367|7529|7534,AR|YWHAB|YWHAZ,-0.25,Ccdc115
Reactome Gene Sets,6,R-HSA-69473,G2/M DNA damage checkpoint,,-2.1,7.2,4,30286,94,134,3,2.2,1.3,7529|7534|79184,YWHAB|YWHAZ|BRCC3,-0.25,Ccdc115
GO Biological Processes,19,GO:2001233,regulation of apoptotic signaling pathway,19_GO:0050896 response to stimulus,-2.1,3.4,3.2,30286,396,134,6,4.5,1.8,367|658|1540|1687|7314|27429,AR|BMPR1B|CYLD|GSDME|UBB|HTRA2,-0.25,Ccdc115
GO Biological Processes,19,GO:1901991,negative regulation of mitotic cell cycle phase transition,19_GO:0048519 negative regulation of biological process,-2.1,5,3.6,30286,181,134,4,3,1.5,4998|55743|79184|92421,ORC1|CHFR|BRCC3|CHMP4C,-0.25,Ccdc115
GO Biological Processes,19,GO:0001936,regulation of endothelial cell proliferation,19_GO:0050789 regulation of biological process,-2.1,5,3.6,30286,181,134,4,3,1.5,2321|3357|7010|9037,FLT1|HTR2B|TEK|SEMA5A,-0.25,Ccdc115
GO Biological Processes,19,GO:0071229,cellular response to acid chemical,19_GO:0050896 response to stimulus,-2.1,7.1,4,30286,95,134,3,2.2,1.3,2742|3184|8452,GLRA2|HNRNPD|CUL3,-0.25,Ccdc115
GO Biological Processes,19,GO:0071774,response to fibroblast growth factor,19_GO:0050896 response to stimulus,-2.1,7.1,4,30286,95,134,3,2.2,1.3,2246|2263|23767,FGF1|FGFR2|FLRT3,-0.25,Ccdc115
GO Biological Processes,19,GO:0001776,leukocyte homeostasis,19_GO:0042592 homeostatic process,-2.1,7.1,4,30286,95,134,3,2.2,1.3,4067|5532|10758,LYN|PPP3CB|TRAF3IP2,-0.25,Ccdc115
GO Biological Processes,19,GO:0034248,regulation of amide metabolic process,19_GO:0008152 metabolic process,-2.1,3,3.1,30286,522,134,7,5.2,1.9,3184|4869|10209|28958|51714|57142|246175,HNRNPD|NPM1|EIF1|COA3|SELENOT|RTN4|CNOT6L,-0.25,Ccdc115
GO Biological Processes,19,GO:0050778,positive regulation of immune response,19_GO:0002376 immune system process,-2.1,2.8,3,30286,654,134,8,6,2,1540|1687|4067|57142|64922|79184|92610|373509,CYLD|GSDME|LYN|RTN4|LRRC19|BRCC3|TIFA|USP50,-0.24,Ccdc115
GO Biological Processes,19,GO:0051493,regulation of cytoskeleton organization,19_GO:0050789 regulation of biological process,-2.1,3,3.1,30286,523,134,7,5.2,1.9,71|830|1540|4869|5734|9037|92421,ACTG1|CAPZA2|CYLD|NPM1|PTGER4|SEMA5A|CHMP4C,-0.24,Ccdc115
KEGG Pathway,24,hsa04360,Axon guidance,,-2.1,5,3.6,30286,182,134,4,3,1.5,658|5532|8633|9037,BMPR1B|PPP3CB|UNC5C|SEMA5A,-0.24,Ccdc115
GO Biological Processes,19,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,19_GO:0050896 response to stimulus,-2,7.1,4,30286,96,134,3,2.2,1.3,3357|4988|64805,HTR2B|OPRM1|P2RY12,-0.24,Ccdc115
GO Biological Processes,19,GO:0006575,cellular modified amino acid metabolic process,19_GO:0008152 metabolic process,-2,4.9,3.6,30286,183,134,4,3,1.5,27306|57515|87769|494143,HPGDS|SERINC1|GGACT|CHAC2,-0.24,Ccdc115
GO Biological Processes,19,GO:0048863,stem cell differentiation,19_GO:0032502 developmental process,-2,4.9,3.6,30286,183,134,4,3,1.5,2263|2823|3357|9037,FGFR2|GPM6A|HTR2B|SEMA5A,-0.24,Ccdc115
Reactome Gene Sets,6,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,,-2,4.9,3.6,30286,183,134,4,3,1.5,367|4869|6613|7150,AR|NPM1|SUMO2|TOP1,-0.24,Ccdc115
KEGG Pathway,24,hsa05215,Prostate cancer,,-2,7,3.9,30286,97,134,3,2.2,1.3,367|2263|3326,AR|FGFR2|HSP90AB1,-0.24,Ccdc115
GO Biological Processes,19,GO:0046545,development of primary female sexual characteristics,19_GO:0022414 reproductive process,-2,7,3.9,30286,97,134,3,2.2,1.3,658|7314|7337,BMPR1B|UBB|UBE3A,-0.24,Ccdc115
GO Biological Processes,19,GO:0009261,ribonucleotide catabolic process,19_GO:0008152 metabolic process,-2,7,3.9,30286,97,134,3,2.2,1.3,226|4907|10846,ALDOA|NT5E|PDE10A,-0.24,Ccdc115
Reactome Gene Sets,6,R-HSA-5693607,Processing of DNA double-strand break ends,,-2,7,3.9,30286,97,134,3,2.2,1.3,6613|7314|79184,SUMO2|UBB|BRCC3,-0.24,Ccdc115
GO Biological Processes,19,GO:1903311,regulation of mRNA metabolic process,19_GO:0008152 metabolic process,-2,3.4,3.2,30286,404,134,6,4.5,1.8,3184|4869|10209|10758|169966|246175,HNRNPD|NPM1|EIF1|TRAF3IP2|TENT5D|CNOT6L,-0.23,Ccdc115
GO Biological Processes,19,GO:0030098,lymphocyte differentiation,19_GO:0002376 immune system process,-2,3.9,3.3,30286,289,134,5,3.7,1.6,1540|5532|5734|10758|10803,CYLD|PPP3CB|PTGER4|TRAF3IP2|CCR9,-0.23,Ccdc115
KEGG Pathway,24,hsa04750,Inflammatory mediator regulation of TRP channels,,-2,6.9,3.9,30286,98,134,3,2.2,1.3,808|3357|5734,CALM3|HTR2B|PTGER4,-0.23,Ccdc115
GO Biological Processes,19,GO:0061013,regulation of mRNA catabolic process,19_GO:0048519 negative regulation of biological process,-2,3.9,3.3,30286,290,134,5,3.7,1.6,3184|4869|10758|169966|246175,HNRNPD|NPM1|TRAF3IP2|TENT5D|CNOT6L,-0.23,Ccdc115
GO Biological Processes,19,GO:0010948,negative regulation of cell cycle process,19_GO:0048519 negative regulation of biological process,-2,3.9,3.3,30286,290,134,5,3.7,1.6,4869|4998|55743|79184|92421,NPM1|ORC1|CHFR|BRCC3|CHMP4C,-0.23,Ccdc115
GO Biological Processes,19,GO:0060349,bone morphogenesis,19_GO:0032502 developmental process,-2,6.8,3.9,30286,99,134,3,2.2,1.3,658|2263|7010,BMPR1B|FGFR2|TEK,-0.22,Ccdc115
GO Biological Processes,19,GO:0030522,intracellular receptor signaling pathway,19_GO:0050896 response to stimulus,-2,4.8,3.5,30286,188,134,4,3,1.5,367|1540|7337|92610,AR|CYLD|UBE3A|TIFA,-0.22,Ccdc115
